Visual disturbances

H7_VISUDISTURB

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H53 Cause of death: ICD-10 — H53 2 out of 7 registries used, show all original rules.	24927
4. Check minimum number of events None	24927
5. Include endpoints H7_AMBLYANOPSIA H7_VISUDISTURBSUB H7_DIPLOPIA H7_BINODISTOTH H7_VISFIELDDEF H7_COULOURVISDEF H7_NIGHTBLIND H7_VISDISTNAS	25360
6. Filter based on genotype QC (FinnGen only)	24510

Control definitions (FinnGen only)

Control exclude: H7_VISUALDISTBLIND

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H53-H54
Name in latin: Perturbationes visus

NAME	H7_VISUDISTURB
CONTROL_EXCLUDE	H7_VISUALDISTBLIND
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	H7_AMBLYANOPSIA\|H7_VISUDISTURBSUB\|H7_DIPLOPIA\|H7_BINODISTOTH\|H7_VISFIELDDEF\|H7_COULOURVISDEF\|H7_NIGHTBLIND\|H7_VISDISTNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H53
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H53
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Visual disturbances based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	163178	89574	72973
Only index persons	148634	83120	65514
Unadjusted period prevalence (%)
Whole population	2.32	2.57	2.04
Only index persons	2.81	3.06	2.50
Median age at first event (years)
Whole population	50.72	51.69	49.53
Only index persons	51.91	52.72	50.87

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	24510	15089	9421
Unadjusted period prevalence (%)	4.95	5.35	4.32
Median age at first event (years)	58.74	56.49	62.33

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
25360: Matched controls
253600

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

323.3

4091

22139

H50.2

ICD-10 Finland

Vertical strabismus

9.0

313.0

386

433

M79.6

ICD-10 Finland

Pain in limb

1.7

312.0

10549

76252

TAB00

NOMESCO Finland

Lumbar puncture

3.5

307.7

1582

4682

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.2

307.7

2391

8035

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.9

307.7

2877

10756

R51.80

ICD-10 Finland

Headache

2.9

307.7

5576

22734

H50.0

ICD-10 Finland

Convergent concomitant strabismus

10.0

307.7

409

415

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

15.7

307.7

596

387

B01AC04

ATC

clopidogrel; oral

2.2

307.7

4347

21934

H53.4

ICD-10 Finland

Visual field defects

220.6

307.7

3648

193

H53.3

ICD-10 Finland

Other disorders of binocular vision

51.5

307.7

584

116

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.2

307.7

6762

25666

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

3.5

307.7

3718

11712

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.9

307.7

1722

6221

CS494

NOMESCO Finland

Other visual field testing

4.7

307.7

990

2185

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

11.3

307.7

514

465

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.7

307.7

3645

11010

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.9

307.7

3492

9971

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.5

307.7

2929

9065

AA1AD

NOMESCO Finland

CT of head and brain

3.4

307.7

10135

41674

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

14.8

307.7

370

254

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.9

307.7

3147

11740

XA800

NOMESCO Finland

Neuropsychological investigation

3.2

307.7

1365

4426

H53.9

ICD-10 Finland

Visual disturbance, unspecified

26.9

307.7

4271

1896

H53.0

ICD-10 Finland

Amblyopia ex anopsia

123.4

307.7

1400

120

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

4.2

307.7

1365

3386

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

3.2

307.7

2186

7294

H43.8

ICD-10 Finland

Other disorders of vitreous body

2.8

307.7

3028

11557

H46

ICD-10 Finland

Optic neuritis

9.9

307.7

487

503

F05

ICPC

Visual disturbance other

5.7

307.7

1468

2703

H53.8

ICD-10 Finland

Other visual disturbances

18.6

307.7

1172

658

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.8

307.7

1784

4894

R20.2

ICD-10 Finland

Paraesthesia of skin

2.7

307.7

2250

8746

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

307.7

10888

76543

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

3.7

307.7

2832

8291

H50.52

ICD-10 Finland

Exophoria

6.7

307.7

555

838

G45.3

ICD-10 Finland

Amaurosis fugax

8.8

307.7

1097

1295

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

307.7

3276

15737

H53.1

ICD-10 Finland

Subjective visual disturbances

87.4

307.7

12417

2753

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

307.7

7406

45769

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

307.7

9493

66238

XCK00

NOMESCO Finland

Perimetry

5.8

307.7

3372

6552

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.6

307.7

1247

2797

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

307.7

12219

82466

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

29.3

307.7

258

PA6AD

NOMESCO Finland

CT of neck arteries

4.6

307.7

1165

2638

G44.2

ICD-10 Finland

Tension-type headache

2.2

307.7

4046

20010

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

4.3

307.7

1313

3210

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.8

307.7

4505

13671

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

4.5

307.7

1547

3635

R42

ICD-10 Finland

Dizziness and giddiness

2.3

307.7

6981

36374

H53.2

ICD-10 Finland

Diplopia

180.1

307.7

5822

419

H53.5

ICD-10 Finland

Colour vision deficiencies

54.7

307.4

174

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

13.7

305.8

284

209

R06.0

ICD-10 Finland

Dyspnoea

1.7

304.0

6759

43611

A02BC02

ATC

pantoprazole; systemic

1.7

303.5

16749

136504

XCD10

NOMESCO Finland

Electrophysiological examination of eye

4.1

296.5

829

2057

R53

ICD-10 Finland

Malaise and fatigue

1.8

294.5

6232

39588

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

4.4

288.0

731

1685

G35

ICD-10 Finland

Multiple sclerosis

5.0

287.7

630

1287

N03AX16

ATC

[U] pregabalin

1.8

286.8

5875

36930

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

3.9

280.4

855

2258

N03AX12

ATC

[U] gabapentin; oral

1.9

280.3

4222

24134

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

273.8

7184

48240

G43.9

ICD-10 Finland

Migraine, unspecified

2.6

272.9

1746

7107

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

8.1

266.4

357

444

N17

ICPC

Vertigo/dizziness

2.0

263.8

3255

17361

Z3231

NOMESCO Finland

Registered nurse

1.7

260.5

6856

45963

CE2W4

NOMESCO Finland

Eye movement mapping

31.7

253.6

164

109

Kela drug reimbursment

Multiple sclerosis

5.6

246.4

469

845

37720

ICD-8 Finland

Other diseases of retina and optic nerve, Amblyopia

+∞

246.2

236

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.9

242.7

3308

18223

N02AX02

ATC

tramadol; systemic, rectal

1.6

241.3

10269

76958

A02BC05

ATC

esomeprazole; systemic

1.6

240.9

9812

72800

H47.2

ICD-10 Finland

Optic atrophy

12.9

240.5

232

182

XCK10

NOMESCO Finland

Photography of fundus of eye

2.1

240.1

2469

12294

M54.5

ICD-10 Finland

Low back pain

1.6

239.9

8768

63439

C07AB07

ATC

bisoprolol; oral

1.5

238.0

11259

86307

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

6.1

237.0

418

700

H50.1

ICD-10 Finland

Divergent concomitant strabismus

7.3

236.6

349

485

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

234.7

5664

36947

N01

ICPC

Headache

2.0

231.0

3039

16522

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.4

230.8

1721

7503

H57.1

ICD-10 Finland

Ocular pain

2.9

229.8

1113

3919

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

6.2

229.1

395

647

N02BE01

ATC

paracetamol; systemic, rectal

1.8

226.5

22071

198891

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

3.6

226.5

768

2179

H51.1

ICD-10 Finland

Convergence insufficiency and excess

12.8

224.3

217

171

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

223.6

4429

27324

N06AX11

ATC

mirtazapine; oral

1.6

223.5

8199

59136

C10AA05

ATC

atorvastatin; oral

1.5

221.6

9488

70804

ZXA10

NOMESCO Finland

Bilateral

1.7

212.3

4574

28842

F29

ICPC

Eye symptom/complaint other

2.0

210.7

2508

13146

H02AB06

ATC

prednisolone; systemic

1.5

209.6

11350

88700

PA7BD

NOMESCO Finland

CT angiography of neck and brain

4.3

209.5

544

1275

N03AX09

ATC

lamotrigine; oral

2.6

208.0

1314

5300

R03AC02

ATC

salbutamol; inhalant

1.5

207.7

13281

107312

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

206.9

5723

38473

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

206.1

5270

34731

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

205.6

2457

12891

H50.31

ICD-10 Finland

Intermittent exotropia

6.1

205.6

358

592

L17

ICPC

Foot/toe symptom/complaint

1.6

204.5

6987

49366

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

203.6

3931

24011

R02

ICPC

Shortness of breath/dyspnoea

1.8

201.1

3281

19061

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.9

200.7

3058

17392

CEC10

NOMESCO Finland

Recession and resection of extraocular muscle

7.0

198.1

303

438

M25.5

ICD-10 Finland

Pain in joint

1.5

195.8

7553

54722

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.8

195.5

1016

3712

H53

ICD-10 Finland

Visual disturbances

6.0

195.1

347

586

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

4.2

193.0

528

1287

H54.7

ICD-10 Finland

Unspecified visual loss

8.6

192.5

245

286

H50.30

ICD-10 Finland

Intermittent esotropy

8.7

190.2

240

277

Z3229

NOMESCO Finland

Other healthcare associate professional

2.0

189.3

2123

10875

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

186.2

3893

24256

M79.1

ICD-10 Finland

Myalgia

1.7

182.0

3515

21412

A04

ICPC

Weakness/tiredness general

1.7

180.0

3687

22823

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

179.9

6114

42916

C07AA05

ATC

propranolol; systemic

1.6

179.7

4847

32225

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

3.1

179.4

790

2633

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

3.3

178.0

692

2141

R07.3

ICD-10 Finland

Other chest pain

1.9

177.6

2503

13851

L03

ICPC

Low back symptom/complaint

1.5

177.6

6595

47183

M03BX02

ATC

tizanidine; oral

1.5

175.7

14527

121623

L01

ICPC

Neck symptom/complaint

1.7

173.7

3764

23637

A11

ICPC

Chest pain NOS

2.0

173.2

2031

10556

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

172.9

4186

27058

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

172.8

6112

43218

R4120

NOMESCO Finland

Occupational therapy

2.2

172.8

1651

7953

S06.0

ICD-10 Finland

Concussion

1.8

172.8

2680

15283

R4110

NOMESCO Finland

Physiotherapy

1.5

172.5

6421

45908

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

6.5

171.5

281

437

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

171.4

17150

148558

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

171.3

5225

35719

N06AX21

ATC

duloxetine; oral

1.8

171.0

2847

16586

J01DB01

ATC

cefalexin; oral

1.6

170.1

20218

181341

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

169.5

9944

77864

XF404

NOMESCO Finland

Ambulatory ECG

2.0

167.5

2131

11389

S18

ICPC

Laceration/cut

1.4

167.4

10602

84155

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

6.2

165.4

283

460

Z2221

NOMESCO Finland

Medical doctor

1.5

165.0

6442

46452

XCH00

NOMESCO Finland

Eye pressure measurement

2.4

163.5

1209

5233

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

163.3

12972

107142

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

161.9

9768

76686

H50.51

ICD-10 Finland

Esophoria

8.1

161.8

217

270

Z71.8

ICD-10 Finland

Other specified counselling

1.5

161.6

7302

54213

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

160.4

3713

23680

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

159.7

1776

9049

Z3226

NOMESCO Finland

Physiotherapist

1.6

159.7

4240

27987

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

159.6

10258

81409

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.3

159.6

1330

6059

R52.9

ICD-10 Finland

Pain, unspecified

1.8

159.2

2419

13688

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

158.8

17201

149976

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

157.9

2405

13617

N03AG01

ATC

valproic acid; systemic, rectal

2.2

157.7

1455

6906

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.3

156.8

1307

5953

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.7

156.7

903

3475

WX002

NOMESCO Finland

Sedation and analgesia

1.6

155.7

4453

29899

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.9

155.4

2243

12482

N05BA04

ATC

oxazepam; oral

1.5

155.0

6017

43234

UJF32

NOMESCO Finland

Coloscopy

1.5

154.0

5967

42847

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

152.0

11402

92747

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

3.7

151.8

492

1353

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

151.8

4278

28607

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

151.7

4267

28517

A02BC03

ATC

lansoprazole; oral

1.5

151.7

6459

47263

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

151.3

3079

18953

B01AA03

ATC

warfarin; systemic

1.6

151.1

4011

26435

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

151.0

6694

49375

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

150.7

6898

51199

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

150.0

3221

20112

R13

ICD-10 Finland

Dysphagia

2.0

149.8

1651

8379

H26.4

ICD-10 Finland

After-cataract

1.8

149.7

2262

12764

R51

ICD-10 Finland

Headache

2.1

148.3

1417

6816

D01

ICPC

Abdominal pain/cramps general

1.7

148.2

2898

17639

H52.0

ICD-10 Finland

Hypermetropia

3.2

148.2

596

1882

Z2445

NOMESCO Finland

Psychologist

2.4

148.1

1038

4384

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

7.4

147.9

215

294

A01

ICPC

Pain general/multiple sites

1.9

147.7

2218

12490

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

6.6

147.6

238

364

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

4.4

147.3

374

861

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

147.0

9171

72066

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

146.5

4089

27255

N06AX16

ATC

venlafaxine; oral

1.7

146.0

3281

20724

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

144.6

3043

18886

J01AA02

ATC

doxycycline; systemic

1.4

143.6

18155

161070

N03AF02

ATC

oxcarbazepine; oral

2.6

142.8

862

3393

L28

ICPC

Limited function/disability (L)

1.6

142.4

3946

26237

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.1

142.2

1411

6884

R01AD09

ATC

mometasone; nasal

1.4

142.0

10486

84711

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

141.7

6972

52347

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

141.5

3095

19399

CEC00

NOMESCO Finland

Recession of extraocular muscle

8.1

141.4

190

237

ZXA05

NOMESCO Finland

Left side

1.5

141.0

5496

39398

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.9

140.8

1926

10521

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

140.8

10886

88595

R55

ICD-10 Finland

Syncope and collapse

1.8

140.7

2550

15178

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

140.1

7504

57225

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

139.9

8072

62394

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

139.8

4732

32915

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

138.5

7499

57273

H52.2

ICD-10 Finland

Astigmatism

3.3

138.4

532

1634

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

137.5

5068

35882

G70.0

ICD-10 Finland

Myasthenia gravis

8.2

137.1

181

221

N03AX14

ATC

levetiracetam; systemic

2.7

136.9

756

2846

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

135.7

8594

67443

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.0

135.4

1463

7364

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

3.2

135.2

545

1723

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

9.0

134.7

166

186

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

134.4

4315

29635

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

134.3

2794

17265

A02BC01

ATC

omeprazole; systemic

1.5

133.7

6167

45639

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

133.4

5047

35898

H54.4

ICD-10 Finland

Blindness, monocular

25.2

133.1

N05AH04

ATC

quetiapine; oral

1.6

133.1

3952

26663

WX140

NOMESCO Finland

Parabulbar anesthesy

2.3

132.7

1093

4948

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

132.3

2960

18637

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.0

132.0

596

2013

N07AA02

ATC

pyridostigmine; systemic

6.7

130.7

208

314

CKC12

NOMESCO Finland

Photocoagulation of retina

2.3

130.5

1012

4466

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

4.4

130.5

334

774

R05

ICPC

Cough

1.5

130.1

5571

40597

K90

ICPC

Stroke/cerebrovascular accident

2.7

128.8

698

2602

R00.2

ICD-10 Finland

Palpitations

1.9

128.7

1852

10272

N05CF01

ATC

zopiclone; oral

1.4

127.5

7113

54442

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

126.9

5529

40399

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

126.0

4261

29549

H47.1

ICD-10 Finland

Papilloedema, unspecified

6.2

126.0

217

355

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

10.2

125.8

141

139

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

125.7

3095

19949

H52.1

ICD-10 Finland

Myopia

2.4

125.6

897

3817

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

125.6

5591

41008

D06

ICPC

Abdominal pain localized other

1.8

125.3

2110

12274

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

124.9

2729

17063

R50.9

ICD-10 Finland

Fever, unspecified

1.6

124.7

3403

22481

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.9

124.7

608

2143

XF402

NOMESCO Finland

ECG with work load test

1.7

124.6

2335

14006

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

124.0

2358

14201

P01AB01

ATC

metronidazole; oral, rectal

1.4

123.9

9040

72368

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

3.2

123.1

506

1618

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

7.0

122.9

186

266

J01MA02

ATC

ciprofloxacin; systemic

1.4

122.1

8598

68378

L12

ICPC

Hand/finger symptom/complaint

1.6

120.9

3717

25222

N06AB04

ATC

citalopram; systemic

1.5

120.8

4623

32868

G47.3

ICD-10 Finland

Sleep apnoea

1.5

120.8

4788

34286

S29

ICPC

Skin symptom/complaint other

1.5

120.0

4350

30579

K30

ICD-10 Finland

Functional dyspepsia

1.7

120.0

2579

16044

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

119.2

6327

47876

E23.00

ICD-10 Finland

Panhypopituitarism

7.2

119.2

176

245

J01FA10

ATC

azithromycin; systemic

1.4

118.8

13369

114341

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

118.6

2171

12927

N03AE01

ATC

clonazepam; systemic

2.0

118.4

1315

6678

R11

ICD-10 Finland

Nausea and vomiting

1.8

118.2

2030

11868

N06AB10

ATC

escitalopram; oral

1.5

118.2

4615

32930

H34.2

ICD-10 Finland

Other retinal artery occlusions

6.2

117.9

202

329

ZXA00

NOMESCO Finland

Right side

1.4

117.7

5738

42734

J01FA06

ATC

roxithromycin; oral

1.4

117.5

8782

70410

G43.8

ICD-10 Finland

Other migraine

3.4

117.2

433

1297

R52.2

ICD-10 Finland

Other chronic pain

2.3

116.9

892

3907

H52.3

ICD-10 Finland

Anisometropia and aniseikonia

4.5

116.8

286

640

N05BA01

ATC

diazepam; systemic, rectal

1.6

116.7

2856

18356

J01CA04

ATC

amoxicillin; systemic

1.4

116.5

19699

179618

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.3

116.4

306

724

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

116.3

6393

48639

Z2446

NOMESCO Finland

Social worker

1.9

115.8

1507

8082

L03AX13

ATC

glatiramer acetate; parenteral

6.6

115.1

184

279

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.7

114.7

635

2393

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

113.8

12031

101639

3680A

ICD-9 Finland

Visual disturbances, Amblyopia ex anopsia

+∞

113.6

109

A02BA02

ATC

ranitidine; systemic

1.5

112.8

4085

28671

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

4.1

112.1

314

779

ZXD05

NOMESCO Finland

Urgent procedure

1.4

112.0

6704

51700

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

111.9

1923

11239

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

7.7

111.6

156

204

L03AB07

ATC

interferon beta-1a; parenteral

5.6

111.6

211

378

C09CA06

ATC

candesartan; oral

1.4

111.2

5165

38055

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

110.9

4118

29039

H02AB09

ATC

hydrocortisone; systemic

2.7

110.4

617

2336

K80

ICPC

Cardiac arrhythmia NOS

1.8

110.1

1841

10671

SFA10

NOMESCO Finland

One-surface restoration

1.3

109.7

12607

107598

ZXE00

NOMESCO Finland

One hour or less

1.4

109.7

8711

70305

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.9

109.5

542

1926

SPAT1263

SPAT

Sampling

1.4

109.4

9668

79319

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

109.0

2559

16261

H33.0

ICD-10 Finland

Retinal detachment with retinal break

2.6

109.0

659

2594

A28

ICPC

Limited function/disability NOS

1.5

108.7

3521

24113

N03AX11

ATC

topiramate; oral

2.6

108.5

624

2397

SPAT1301

SPAT

No procedures

1.4

108.4

7145

55939

G43.3

ICD-10 Finland

Complicated migraine

3.1

108.3

453

1464

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.0

108.1

496

1690

N02BF01

ATC

gabapentin; oral

1.8

107.8

1825

10616

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

107.6

4470

32216

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

107.2

1053

5107

WX892

NOMESCO Finland

Monitored bed care

1.8

106.8

1687

9611

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.6

106.5

359

1014

M54.2

ICD-10 Finland

Cervicalgia

1.8

105.4

1763

10215

K02.1

ICD-10 Finland

Caries of dentine

1.3

105.3

13502

116791

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.4

105.1

779

3368

UKC02

NOMESCO Finland

Cystoscopy

1.5

104.8

3296

22415

C10AX09

ATC

ezetimibe; oral

1.5

104.6

3234

21910

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

104.6

2231

13827

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

104.2

4940

36477

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

103.7

2213

13716

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

4.0

103.3

294

738

R21

ICPC

Throat symptom/complaint

1.4

103.2

4822

35498

J02AC01

ATC

fluconazole; systemic

1.3

102.9

8819

71817

C03CA01

ATC

furosemide; systemic

1.4

102.6

6097

46830

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

102.2

1358

7327

R06AE07

ATC

cetirizine; oral

1.3

102.1

10005

83084

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.7

101.9

2195

13633

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

101.7

3086

20810

H54.5

ICD-10 Finland

Severe visual impairment, monocular

7.3

101.6

148

203

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

101.6

15567

137820

PA6CG

NOMESCO Finland

Extensive MRI examination of neck vasculature with high intensity magnet

6.8

101.5

159

236

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

100.4

2202

13737

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

100.1

2026

12377

H02.4

ICD-10 Finland

Ptosis of eyelid

2.4

100.0

701

2956

108

Kela drug reimbursment

Myasthenia gravis

7.9

100.0

137

175

M03BX01

ATC

baclofen; systemic

2.9

100.0

465

1597

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

4.2

99.9

267

640

J01DA01

ATC

[U] cefalexin

1.3

99.4

13987

122129

G93.2

ICD-10 Finland

Benign intracranial hypertension

9.4

99.3

118

126

R60.0

ICD-10 Finland

Localized oedema

1.6

99.2

2655

17390

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.1

98.6

1034

5138

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

98.4

1480

8302

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

98.0

3900

27814

C07AB02

ATC

metoprolol; systemic

1.5

97.9

4134

29824

G50.1

ICD-10 Finland

Atypical facial pain

2.9

97.7

462

1601

J01FF01

ATC

clindamycin; systemic

1.4

97.4

5847

44914

R05

ICD-10 Finland

Cough

1.4

96.9

4692

34716

SFA20

NOMESCO Finland

Two-surface restoration

1.3

96.8

13192

114478

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

96.6

3099

21137

S21

ICPC

Skin texture symptom/complaint

1.5

96.4

3141

21493

R4150

NOMESCO Finland

Neuropsychological rehabilitation

4.5

96.3

237

533

R74

ICPC

Upper respiratory infection acute

1.4

96.3

7088

56252

C08CA01

ATC

amlodipine; oral

1.3

95.7

7990

64620

Z01.2

ICD-10 Finland

Dental examination

1.3

95.6

10340

86825

C10AA01

ATC

simvastatin; oral

1.3

94.8

8684

71178

L04

ICPC

Chest symptom/complaint

1.8

94.7

1406

7854

164

Kela drug reimbursment

Fingolimod

7.6

94.6

134

178

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

94.4

2104

13171

E0000UV, ,

ATC

1.3

94.2

9402

77997

N30.0

ICD-10 Finland

Acute cystitis

1.5

93.9

3646

25856

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

93.7

7868

63638

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

93.7

12954

112408

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.5

93.4

332

971

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

93.4

1957

12057

R03DC03

ATC

montelukast; oral

1.5

93.3

3600

25493

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

93.1

1444

8174

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.6

92.6

2530

16636

SPAT1260

SPAT

Consultation of another employee

1.5

92.2

3945

28496

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.3

92.1

358

1107

M01AE02

ATC

naproxen; oral, rectal

1.3

91.7

12836

111426

D11

ICPC

Diarrhoea

1.6

91.4

2605

17294

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

90.9

9321

77503

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.9

90.7

1218

6589

R51.81

ICD-10 Finland

Facial pain NOS

2.5

90.6

575

2316

L04AX07

ATC

dimethyl fumarate; oral

6.5

90.4

146

224

C10AA07

ATC

rosuvastatin; oral

1.4

89.9

6574

52002

H03AA01

ATC

levothyroxine sodium; systemic

1.4

89.8

5096

38695

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

89.7

2496

16476

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

3.7

89.7

287

783

H34.1

ICD-10 Finland

Central retinal artery occlusion

5.4

89.4

175

324

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

89.2

1693

10152

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

4.1

89.0

244

596

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

88.9

1095

5755

K89

ICPC

Transient cerebral ischaemia

3.8

88.9

271

715

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

88.8

1747

10578

N86

ICPC

Multiple sclerosis

4.7

88.7

206

442

B01AC07

ATC

dipyridamole; systemic

2.2

88.7

815

3850

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.9

88.6

1133

6030

KMAK, ,

NOMESCO Finland

1.3

88.4

11352

97212

N06AA09

ATC

amitriptyline; systemic

1.6

88.4

2031

12803

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

88.1

8101

66246

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

87.8

2145

13728

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

87.5

827

3950

N06AB06

ATC

sertraline; oral

1.6

87.1

2430

16044

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

87.0

4224

31192

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

3.7

86.8

280

768

U02

ICPC

Urinary frequency/urgency

1.5

86.5

3122

21785

C01DA14

ATC

isosorbide mononitrate; oral

1.5

86.2

2933

20221

K07.60

ICD-10 Finland

Snapping jaw

1.9

85.8

1149

6207

L08

ICPC

Shoulder symptom/complaint

1.4

85.7

4622

34755

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

85.6

5253

40358

D02

ICPC

Abdominal pain epigastric

1.8

85.4

1372

7844

L02

ICPC

Back symptom/complaint

1.6

84.6

2195

14245

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.8

84.6

256

672

SPAT1097

SPAT

Recording of ECG

1.5

84.5

3068

21426

X58

ICD-10 Finland

Exposure to other specified factors

1.5

84.4

2996

20828

H93.1

ICD-10 Finland

Tinnitus

1.7

84.3

1479

8672

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.9

84.2

1026

5371

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

84.0

4373

32670

R01AD08

ATC

fluticasone; nasal

1.4

83.5

6156

48649

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

83.4

5752

44996

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

83.2

2793

19189

H52.5

ICD-10 Finland

Disorders of accommodation

8.6

83.2

106

124

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

82.9

1590

9557

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

82.8

1979

12590

ZY010

NOMESCO Finland

Hospital outpatient

1.9

82.8

1123

6092

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

82.0

3239

22992

N06AB03

ATC

fluoxetine; oral

1.5

81.7

2610

17741

101

Kela drug reimbursment

Anterior pituitary hypofunction

4.4

81.1

205

471

353

Kela drug reimbursment

Cladribine and fingolimod

7.2

80.9

119

165

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

80.2

3309

23676

N03AF01

ATC

carbamazepine; oral, rectal

1.9

80.0

1038

5548

H25.0

ICD-10 Finland

Senile incipient cataract

1.8

79.9

1327

7658

H02AB07

ATC

prednisone; oral

1.5

79.8

2842

19755

H29

ICPC

Ear symptom/complaint other

1.5

79.7

2453

16535

B01AB05

ATC

enoxaparin; parenteral

1.3

79.7

6731

54199

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

4.4

79.7

199

453

H02AB04

ATC

methylprednisolone; systemic

1.5

79.6

3019

21249

SPAT1216

SPAT

Assessment of functional ability

1.5

79.6

3213

22893

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

4.9

79.5

176

363

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.0

79.4

892

4539

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.7

79.2

1505

9019

A29

ICPC

General symptom/complaint other

1.5

78.6

2650

18209

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

3.3

78.6

305

943

H01

ICPC

Ear pain/earache

1.5

78.5

2555

17427

A03

ICPC

Fever

1.4

78.5

3681

26963

H54.1

ICD-10 Finland

Severe visual impairment, binocular

28.0

78.5

H40.0

ICD-10 Finland

Glaucoma suspect

1.7

78.2

1657

10220

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

78.2

4683

35762

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

78.1

2242

14880

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

77.8

2299

15355

SPAT1310

SPAT

Counselling related to known health issue

1.3

77.5

7021

57051

J05AB01

ATC

aciclovir; systemic

1.4

77.3

4617

35236

P20

ICPC

Memory disturbance

1.5

77.1

2639

18188

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

77.1

3448

25033

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

77.0

1849

11767

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

76.9

6291

50376

A98

ICPC

Health maint/preventive medicine

1.7

76.7

24087

232397

-1, ,

NOMESCO Finland

1.3

76.7

7261

59344

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

76.4

1954

12626

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

3.5

76.3

260

740

R01AD58

ATC

fluticasone, combinations; nasal

1.4

76.3

5173

40267

R03BA02

ATC

budesonide; inhalant

1.4

76.2

3799

28114

R06AX27

ATC

desloratadine; oral

1.3

76.1

6182

49436

N89

ICPC

Migraine

2.1

75.8

767

3759

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

75.6

2905

20483

R07.0

ICD-10 Finland

Pain in throat

1.7

75.6

1531

9330

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

75.6

1287

7478

H50.9

ICD-10 Finland

Strabismus, unspecified

7.1

75.4

113

160

L15

ICPC

Knee symptom/complaint

1.4

75.3

5090

39590

M01AB05

ATC

diclofenac; systemic, rectal

1.3

75.1

14698

131601

SFA30

NOMESCO Finland

Three-surface restoration

1.3

75.0

8950

75371

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.4

74.9

517

2165

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

74.4

4144

31240

D07AC01

ATC

betamethasone; topical

1.3

74.4

7717

63794

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

74.2

1667

10432

L04AA27

ATC

[U] fingolimod

8.2

74.2

120

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

73.8

754

3708

WX290

NOMESCO Finland

Other blockage of nerve

1.3

73.7

10136

86839

K04

ICPC

Palpitations/awareness of heart

1.8

73.4

1143

6469

R03BA05

ATC

fluticasone; inhalant

1.4

73.3

3898

29151

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.6

73.3

2046

13485

N18

ICPC

Paralysis/weakness

2.6

73.2

439

1721

XQ800

NOMESCO Finland

Prick test

1.7

73.2

1573

9734

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

73.2

1400

8402

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

73.1

3539

26037

H54.3

ICD-10 Finland

Mild or no visual impairment, binocular

8.7

73.1

106

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

73.0

1320

7799

R04.0

ICD-10 Finland

Epistaxis

1.7

73.0

1514

9283

C01CA24

ATC

epinephrine; parenteral

1.7

72.8

1316

7776

DFF00

NOMESCO Finland

Pure tone audiometry

1.6

72.8

2050

13538

183

Kela drug reimbursment

Lamotrigin and topiramate

3.6

72.7

244

688

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.5

72.6

476

1947

K08.80

ICD-10 Finland

Toothache NOS

1.6

72.4

1841

11872

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

72.3

2364

16124

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

72.1

1867

12090

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

72.0

2340

15938

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

2.9

71.9

332

1136

T78.4

ICD-10 Finland

Allergy, unspecified

1.9

71.7

1002

5485

SPAT1240

SPAT

Therapeutic discussion

1.5

71.6

2246

15185

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

71.5

1757

11238

AN1

Coronary angiography

1.5

71.5

2108

14062

L05

ICPC

Flank/axilla symptom/complaint

1.7

71.3

1267

7450

C09AA05

ATC

ramipril; oral

1.4

71.2

4918

38335

P06

ICPC

Sleep disturbance

1.5

71.1

2466

17022

N05CF02

ATC

zolpidem; oral

1.4

71.1

3603

26709

SPAT1153

SPAT

Removal of sutures

1.3

70.9

6639

54053

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.7

70.6

1246

7311

C08DA01

ATC

verapamil; systemic

2.0

70.6

850

4431

U07

ICPC

Urine symptom/complaint other

1.6

70.5

1563

9747

L13

ICPC

Hip symptom/complaint

1.4

70.4

3764

28153

B01AF02

ATC

apixaban; oral

1.5

70.3

2487

17237

PAW37

NOMESCO Finland

Biopsy of temporal artery

4.0

70.3

203

516

J01EA01

ATC

trimethoprim; systemic

1.3

70.2

5594

44514

R12

ICD-10 Finland

Heartburn

1.6

70.2

1701

10841

R03BA08

ATC

ciclesonide; inhalant

1.6

70.0

1816

11764

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

69.6

5044

39577

H33.3

ICD-10 Finland

Retinal breaks without detachment

2.0

69.5

729

3619

F01

ICPC

Eye pain

2.1

69.4

660

3158

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

2.2

69.2

609

2828

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.2

69.1

626

2940

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.6

69.1

1711

10961

CEW99

NOMESCO Finland

Other operation on extraocular muscle

14.0

68.9

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.6

68.9

1607

10148

L29

ICPC

Musculoskeletal sympt/complt other

1.6

68.8

1807

11736

M79.7

ICD-10 Finland

Fibromyalgia

2.0

68.8

763

3865

A06AD11

ATC

lactulose; oral

1.4

68.6

2853

20398

R01AD12

ATC

fluticasone furoate; nasal

1.3

68.3

6702

54850

R96

ICPC

Asthma

1.5

68.3

2009

13388

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.3

68.3

509

2206

CEC60

NOMESCO Finland

Transposition of extraocular muscle with adjustable suture

13.7

68.0

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.0

67.7

739

3721

P01

ICPC

Feeling anxious/nervous/tense

1.5

67.6

2530

17726

K91

ICPC

Cerebrovascular disease

3.0

67.5

304

1026

H54.6

ICD-10 Finland

Moderate visual impairment, monocular

7.2

67.5

100

140

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

67.3

853

4523

207

Kela drug reimbursment

Chronic arrhythmias

1.4

67.3

3023

21921

M01AH05

ATC

etoricoxib; oral

1.3

67.2

13508

120538

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

67.1

2109

14253

N02BF02

ATC

pregabalin; oral

1.7

66.9

1210

7146

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

66.8

2254

15463

N02AA05

ATC

oxycodone; systemic

1.4

66.8

3433

25487

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

66.7

1170

6851

R03AC03

ATC

terbutaline; inhalant

1.4

66.7

2887

20791

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

66.6

3267

24057

J01FA09

ATC

clarithromycin; systemic

1.3

66.6

6621

54249

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

66.3

1878

12406

WX402

NOMESCO Finland

General anaesthesia

1.4

66.3

4417

34190

L04AA31

ATC

[U] teriflunomide

6.3

66.2

110

174

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

66.1

2687

19121

H81.3

ICD-10 Finland

Other peripheral vertigo

2.1

66.0

617

2934

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

3.7

65.6

209

569

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

65.5

4920

38762

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

65.3

1547

9801

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

65.2

2512

17689

S01ED51

ATC

timolol, combinations; ophthalmic

1.6

65.0

1476

9254

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

64.9

3054

22315

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

64.9

8657

73536

I63.8

ICD-10 Finland

Other cerebral infarction

3.5

64.8

224

644

H02

ICPC

Hearing complaint

1.4

64.8

2765

19852

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

64.7

1895

12608

SPAT1229

SPAT

Assessment of need for aid

1.6

64.6

1546

9818

Z00.0

ICD-10 Finland

General medical examination

1.4

64.2

4086

31385

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

64.2

1831

12111

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

64.0

1406

8741

A99

ICPC

Disease/condition unspecnature/site

1.5

63.7

1919

12845

L16

ICPC

Ankle symptom/complaint

1.5

63.7

2394

16775

W19

ICD-10 Finland

Unspecified fall

1.5

63.6

2006

13560

N06AX26

ATC

vortioxetine; oral

1.6

63.6

1481

9341

R35

ICD-10 Finland

Polyuria

1.7

63.6

1321

8095

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.0

63.5

740

3813

M54.8

ICD-10 Finland

Other dorsalgia

1.8

63.5

947

5288

XKD00

NOMESCO Finland

Uroflowmetry

1.4

63.4

2871

20833

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.7

63.2

353

1337

S01EC01

ATC

acetazolamide; systemic

2.4

63.2

458

1961

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

3.1

63.1

261

839

N07CA01

ATC

betahistine; oral

1.6

62.9

1463

9224

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.5

62.9

398

1602

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

62.8

4055

31206

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

62.6

1055

6107

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

62.6

1562

10018

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

62.5

4189

32417

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.8

62.5

937

5239

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.5

62.4

1931

12998

H50.8

ICD-10 Finland

Other specified strabismus

8.4

62.1

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

62.1

935

5236

SPAT1254

SPAT

Administration of medicine

1.4

61.7

3124

23103

PA2AD

NOMESCO Finland

CT angiography of brain

3.4

61.7

222

655

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

2.7

61.7

325

1195

A97

ICPC

No disease

1.4

61.6

3800

29027

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

61.5

1921

12959

H43.3

ICD-10 Finland

Other vitreous opacities

2.7

61.3

327

1210

315

Kela drug reimbursment

Clopidogrel

3.3

61.3

235

722

S04

ICPC

Lump/swelling localized

1.5

61.2

2152

14873

WX872

NOMESCO Finland

Intensive care

1.8

61.1

991

5672

SPAT1312

SPAT

General health counselling

1.3

61.0

6968

57977

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

60.9

865

4757

M01AH01

ATC

celecoxib; oral

1.4

60.9

3606

27364

CEC30

NOMESCO Finland

Resection of extraocular muscle

9.3

60.9

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

60.8

3261

24349

G45.8

ICD-10 Finland

Other transient cerebral ischaemic attacks and related syndromes

4.0

60.8

172

431

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

60.7

4001

30867

M48.0

ICD-10 Finland

Spinal stenosis

1.5

60.7

2411

17068

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

1.9

60.5

725

3772

J20

ICD-10 Finland

Acute bronchitis

1.5

60.4

2094

14431

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

60.2

1541

9941

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

60.2

1133

6764

D12

ICPC

Constipation

1.9

60.1

746

3928

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

2.5

59.7

388

1582

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

59.6

968

5544

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.9

59.5

785

4216

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

59.5

6613

54795

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

2.8

59.4

300

1079

H92.0

ICD-10 Finland

Otalgia

1.7

59.2

1268

7829

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

59.2

1258

7754

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.5

59.1

389

1595

N29

ICPC

Neurological sympt/complt other

2.4

59.1

426

1820

R83

ICPC

Respiratory infection other

1.3

58.9

5332

43018

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.1

58.9

550

2615

Z00.8

ICD-10 Finland

Other general examinations

1.6

58.6

1625

10675

CKD40

NOMESCO Finland

Endophotocoagulation of retina

2.8

58.5

300

1088

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.5

58.4

370

1490

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.0

58.3

670

3437

N04BC05

ATC

pramipexole; oral

1.6

58.1

1508

9759

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.8

58.0

867

4842

37300

ICD-8 Finland

Strabismus, Concomitans convergens

3.9

58.0

170

437

ZXD20

NOMESCO Finland

Day surgery

1.4

58.0

2579

18633

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

57.7

959

5527

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

57.7

2101

14617

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.5

57.5

356

1418

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

57.5

2793

20491

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

3.1

57.5

245

802

D35.30

ICD-10 Finland

Craniopharyngoma

20.0

57.3

J01MA12

ATC

levofloxacin; systemic

1.4

57.2

3627

27791

WX704

NOMESCO Finland

Intubation

1.5

57.1

1638

10839

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.7

57.1

1067

6355

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

57.0

5650

46095

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

2.3

56.9

459

2057

M54.1

ICD-10 Finland

Radiculopathy

1.8

56.8

804

4417

N05BA09

ATC

clobazam; oral

3.8

56.7

170

444

R03BA01

ATC

beclometasone; inhalant

1.4

56.7

2822

20790

A05

ICPC

Feeling ill

1.6

56.5

1323

8352

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

56.4

977

5699

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

56.3

5816

47690

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

2.9

56.1

271

952

S80.0

ICD-10 Finland

Contusion of knee

1.6

55.8

1500

9781

Z01.7

ICD-10 Finland

Laboratory examination

1.4

55.8

2952

21967

N03AX18

ATC

lacosamide; systemic

3.4

55.8

202

599

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

2.8

55.7

290

1060

D09

ICPC

Nausea

1.7

55.7

987

5794

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

3.0

55.7

245

817

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

3.1

55.5

238

782

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.1

55.3

567

2792

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

55.2

5295

42990

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

55.1

1246

7799

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

54.7

1983

13775

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.6

54.7

1410

9105

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

54.6

1149

7061

H34.8

ICD-10 Finland

Other retinal vascular occlusions

2.3

54.6

431

1915

G04CA02

ATC

tamsulosin; oral

1.3

54.6

4052

31763

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

54.5

5458

44544

L14

ICPC

Leg/thigh symptom/complaint

1.5

54.5

1617

10777

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

54.4

1996

13901

P76

ICPC

Depressive disorder

1.6

54.3

1318

8392

EBA00

NOMESCO Finland

Extraction of tooth

1.3

54.3

7567

64258

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

54.2

4698

37621

P03

ICPC

Feeling depressed

1.5

54.0

2029

14195

K59.0

ICD-10 Finland

Constipation

1.7

53.9

1134

6970

G45

ICD-10 Finland

Transient cerebral ischaemic attacks and related syndromes

3.7

53.7

169

457

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

53.7

5447

44518

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

53.7

2190

15563

L86

ICPC

Back syndrome with radiating pain

1.6

53.6

1217

7622

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.9

53.6

669

3528

A02BC04

ATC

rabeprazole; oral

1.5

53.4

1718

11650

D44.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pituitary gland

6.2

53.3

148

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

53.2

1453

9506

I95.1

ICD-10 Finland

Orthostatic hypotension

1.9

53.1

708

3815

3681A

ICD-9 Finland

Visual disturbances, Subjective visual disturbances

+∞

53.1

3682A

ICD-9 Finland

Visual disturbances, Diplopia

+∞

53.1

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

53.1

879

5060

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

53.1

1409

9159

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

53.1

2727

20182

R4130

NOMESCO Finland

Speech therapy

2.1

53.0

506

2426

H35.5

ICD-10 Finland

Hereditary retinal dystrophy

5.3

53.0

105

197

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

52.8

1255

7948

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.0

52.8

562

2806

N06AX12

ATC

bupropion; oral

1.6

52.6

1357

8762

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.7

52.5

922

5397

SPAT1050

SPAT

Extensive neurological examination

2.2

52.5

461

2140

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

3.1

52.4

216

694

S22.3

ICD-10 Finland

Fracture of rib

1.6

52.0

1325

8533

C10AA03

ATC

pravastatin; oral

1.6

52.0

1356

8780

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.8

51.9

263

948

R52.0

ICD-10 Finland

Acute pain

1.9

51.8

672

3589

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.1

51.8

495

2375

M02AA07

ATC

piroxicam; topical

1.2

51.7

7267

61682

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

51.7

4174

33076

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.8

51.6

827

4717

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

51.5

6035

50154

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

51.3

4267

33952

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

51.1

1373

8948

J05AB11

ATC

valaciclovir; oral

1.4

51.1

2863

21483

N05BA12

ATC

alprazolam; oral

1.5

51.1

1918

13409

J45

ICD-10 Finland

Asthma

1.4

50.9

2091

14869

SAA04

NOMESCO Finland

Special examination of mouth

1.6

50.7

1110

6888

2AB04, ,

NOMESCO Finland

6.2

50.7

139

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

50.7

1284

8257

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

50.6

1167

7337

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

50.6

1196

7565

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

1.8

50.6

763

4274

K78

ICPC

Atrial fibrillation/flutter

1.5

50.4

1417

9331

I49.1

ICD-10 Finland

Atrial premature depolarization

1.8

50.3

731

4047

J01DA09

ATC

[U] cefadroxil

1.3

50.2

5365

44071

T90.5

ICD-10 Finland

Sequelae of intracranial injury

2.9

50.1

243

856

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

50.0

2706

20187

M54

ICD-10 Finland

Dorsalgia

1.4

50.0

2465

18107

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

50.0

10566

93558

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

49.4

1097

6833

J45.1

ICD-10 Finland

Nonallergic asthma

1.5

49.3

1449

9631

L03AB08

ATC

interferon beta-1b; parenteral

5.6

49.2

167

H47.3

ICD-10 Finland

Other disorders of optic disc

4.7

49.2

113

241

D19

ICPC

Teeth/gum symptom/complaint

1.3

49.1

5819

48373

G04BD12

ATC

mirabegron; oral

1.4

49.0

2274

16527

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.7

48.8

945

5683

H50.6

ICD-10 Finland

Mechanical strabismus

16.4

48.7

114

Kela drug reimbursment

Glaucoma

1.5

48.6

1590

10810

S01

ICPC

Pain/tenderness of skin

1.7

48.6

916

5466

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.8

48.5

812

4689

R09

ICPC

Sinus symptom/complaint

1.5

48.5

1627

11122

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

48.3

2566

19076

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.1

48.3

464

2230

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

3.0

48.2

215

723

R06.5

ICD-10 Finland

Mouth breathing

1.5

48.2

1682

11589

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

48.0

1228

7913

S16

ICPC

Bruise/contusion

1.9

48.0

640

3450

R25.2

ICD-10 Finland

Cramp and spasm

2.0

47.9

497

2458

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

3.0

47.9

209

694

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

47.9

427

1994

G44.8

ICD-10 Finland

Other specified headache syndromes

2.5

47.9

316

1298

C09CA01

ATC

losartan; oral

1.3

47.9

4978

40717

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

5.6

47.9

161

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

47.8

1366

9023

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

47.8

4604

37301

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

47.7

1019

6286

I20.09

ICD-10 Finland

Unstable angina

1.7

47.6

1006

6187

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.7

47.6

868

5135

H35.6

ICD-10 Finland

Retinal haemorrhage

3.5

47.5

161

458

ZX120

NOMESCO Finland

Intravenous

1.5

47.5

1826

12821

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

2.9

47.3

224

779

P29

ICPC

Psychological sympt/compl other

1.5

47.1

1375

9127

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.3

47.0

349

1511

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.0

47.0

532

2714

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.8

47.0

243

886

PA6AM

NOMESCO Finland

Simple MRI examination of neck vasculature with 3 Tesla magnet

7.0

46.9

102

G44.0

ICD-10 Finland

Cluster headache syndrome

2.7

46.8

246

904

R31

ICD-10 Finland

Unspecified haematuria

1.5

46.8

1835

12929

KH1AD

NOMESCO Finland

CT of urinary organs

1.9

46.6

650

3553

C08CA13

ATC

lercanidipine; oral

1.4

46.6

2729

20603

M54.3

ICD-10 Finland

Sciatica

1.6

46.6

1156

7395

K07

ICPC

Swollen ankles/oedema

1.7

46.6

875

5218

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.8

46.6

661

3634

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

46.6

1075

6759

H25.8

ICD-10 Finland

Other senile cataract

1.4

46.5

1976

14129

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

5.6

46.5

155

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

46.4

2386

17641

N28

ICPC

Limited function/disability (N)

2.4

46.3

335

1434

U05

ICPC

Urination problems other

1.7

46.3

963

5897

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

46.1

1251

8170

L04AX01

ATC

azathioprine; systemic

1.7

46.1

842

4984

102

Kela drug reimbursment

Diabetes insipidus

6.2

46.1

126

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.6

46.0

1018

6333

R1250

NOMESCO Finland

Evaluation of functional capability

2.1

46.0

444

2139

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

45.9

6577

55789

F95

ICPC

Strabismus

9.5

45.9

SPAT1325

SPAT

Vaccination

1.2

45.9

7029

60055

R52.1

ICD-10 Finland

Chronic intractable pain

2.9

45.9

210

717

H13

ICPC

Plugged feeling ear

1.3

45.7

3751

29739

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.9

45.6

596

3191

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

2.6

45.6

256

973

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.6

45.6

1167

7520

ZXY02

NOMESCO Finland

Neuropsychologist

3.7

45.5

142

382

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.1

45.5

426

2028

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

4.5

45.5

111

249

N06AA10

ATC

nortriptyline; systemic

2.1

45.4

415

1958

M05BA04

ATC

alendronic acid; oral

1.5

45.3

1616

11178

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.3

45.2

328

1407

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.6

45.2

1203

7822

A03FA02

ATC

cisapride; oral, rectal

1.5

45.2

1427

9631

S82

ICPC

Naevus/mole

1.4

45.1

2677

20246

P74

ICPC

Anxiety disorder/anxiety state

1.7

45.1

828

4908

K85

ICPC

Elevated blood pressure

1.3

45.0

3064

23654

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.1

45.0

434

2090

F28

ICPC

Limited function/disability (F)

3.4

44.8

159

466

R25.1

ICD-10 Finland

Tremor, unspecified

1.9

44.8

601

3246

L84

ICPC

Back syndrome without radiat pain

1.7

44.8

917

5595

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.4

44.7

2446

18260

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

44.6

4748

38897

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

44.6

2020

14609

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

44.6

3074

23778

R06.4

ICD-10 Finland

Hyperventilation

2.3

44.3

340

1494

J01CA08

ATC

pivmecillinam; oral

1.2

44.1

8644

75664

K04.0

ICD-10 Finland

Pulpitis

1.4

44.0

1759

12432

CK9F4

NOMESCO Finland

Fluorescein angiography (FAG) of choroid and retina

3.3

44.0

162

486

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.9

43.9

607

3310

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

43.9

1486

10171

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.7

43.8

821

4892

M01AX17

ATC

nimesulide; oral

1.3

43.8

4615

37753

L20

ICPC

Joint symptom/complaint NOS

1.7

43.8

743

4308

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

43.6

2055

14961

S02.30

ICD-10 Finland

Fracture of orbital floor, closed

3.0

43.4

190

633

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

43.1

1615

11274

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.7

43.1

877

5340

G43

ICD-10 Finland

Migraine

1.6

43.1

975

6099

M01AC06

ATC

meloxicam; systemic, rectal

1.2

43.0

7279

62744

U01

ICPC

Dysuria/painful urination

1.5

43.0

1578

10975

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.1

43.0

402

1914

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

3.3

42.9

159

479

ZXC95

NOMESCO Finland

Use of surgical navigator

2.5

42.8

260

1028

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

42.8

937

5814

R20.8

ICD-10 Finland

Other and unspecified disturbances of skin sensation

2.6

42.7

240

914

G40.10

ICD-10 Finland

Simple partial seizures

3.2

42.6

171

541

R4110, ,

SPAT

1.5

42.6

1644

11542

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

42.6

1947

14100

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

2.4

42.5

290

1210

N05AH03

ATC

olanzapine; systemic

1.6

42.5

1140

7422

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.1

42.5

390

1843

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

42.4

2498

18862

R09.1

ICD-10 Finland

Pleurisy

2.2

42.2

363

1672

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.9

42.2

546

2915

M01AG02

ATC

tolfenamic acid; oral, rectal

1.3

42.2

2851

21973

S01EE01

ATC

latanoprost; ophthalmic

1.6

42.2

1134

7388

H50.4

ICD-10 Finland

Other and unspecified heterotropia

10.2

42.1

R47.0

ICD-10 Finland

Dysphasia and aphasia

2.8

42.1

206

730

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.7

41.9

747

4390

L18

ICPC

Muscle pain

1.7

41.9

821

4950

SPAT1307

SPAT

Psychosocial counselling and guidance

1.5

41.9

1220

8091

N05AX12

ATC

aripiprazole; systemic

1.7

41.8

738

4326

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.7

41.7

727

4246

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.9

41.7

562

3040

H43.9

ICD-10 Finland

Disorder of vitreous body, unspecified

2.9

41.7

198

690

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.9

41.7

537

2863

A07AA02

ATC

nystatin; oral

1.6

41.7

1115

7256

H50.59

ICD-10 Finland

Heterophor UNS

8.6

41.6

S20.2

ICD-10 Finland

Contusion of thorax

1.6

41.6

974

6144

G51.0

ICD-10 Finland

Bell palsy

1.9

41.5

496

2579

A27

ICPC

Fear of other disease NOS

1.6

41.5

934

5834

H16.0

ICD-10 Finland

Corneal ulcer

1.6

41.4

901

5582

SGA01

NOMESCO Finland

Emergency treatment

1.3

41.3

3104

24281

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.5

41.3

1147

7526

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

41.3

2156

15964

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.6

41.3

246

964

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.6

41.2

890

5503

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.7

41.2

695

4023

N04BB01

ATC

amantadine; oral

2.3

41.2

313

1370

H51.2

ICD-10 Finland

Internuclear ophthalmoplegia

9.6

41.2

SFA00

NOMESCO Finland

Small restoration

1.3

41.1

2675

20500

H33.5

ICD-10 Finland

Other retinal detachments

3.0

41.1

180

600

H54.0

ICD-10 Finland

Blindness, binocular

67.2

41.0

H48.1*G35

ICD-10 Finland

Retrobulbar neuritis in multiple sclerosis

12.1

41.0

PA2DG

NOMESCO Finland

Very extensive MRI examination of vessels in the head with high intensity magnet

8.8

41.0

N07XX09

ATC

[U] dimethyl fumarate

5.6

40.9

138

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

1.8

40.9

674

3876

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

40.9

15132

140105

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

40.8

1553

10872

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

40.8

829

5048

XCW12

NOMESCO Finland

Assessment of colour vision

14.3

40.7

A08

ICPC

Swelling

1.6

40.7

952

6003

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

1.7

40.7

688

3986

R01AD01

ATC

beclometasone; nasal

1.3

40.6

2920

22699

K04.08

ICD-10 Finland

Other specified pulpit

1.5

40.6

1392

9550

H01.0

ICD-10 Finland

Blepharitis

1.5

40.5

1252

8406

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.6

40.5

1114

7293

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

3.5

40.5

136

385

ZXD35

NOMESCO Finland

Usual procedure

1.8

40.3

625

3530

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

40.3

7249

62769

K92.1

ICD-10 Finland

Melaena

1.6

40.3

962

6096

G04CA01

ATC

alfuzosin; oral

1.4

40.3

2033

14966

PA2CG

NOMESCO Finland

Extensive MRI examination of vessels in the head with high intensity magnet

4.3

40.2

102

236

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.1

40.2

393

1903

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

40.2

1303

8838

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.8

40.2

673

3888

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

40.2

1611

11390

A01AB09

ATC

miconazole; local oral

1.4

40.0

1673

11919

UJH02

NOMESCO Finland

Anoscopy

1.7

39.8

776

4674

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.9

39.7

480

2506

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

1.9

39.7

469

2430

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

3.1

39.6

163

524

N30

ICD-10 Finland

Cystitis

1.4

39.5

1603

11357

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

39.5

3458

27600

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

3.0

39.5

173

577

UDC00

NOMESCO Finland

Ear microscopy

1.5

39.1

1449

10090

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

39.1

8622

76075

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

39.1

2851

22201

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

4.4

39.0

217

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.6

39.0

898

5642

A91

ICPC

Abnormal result investigation NOS

1.6

38.9

905

5699

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.6

38.8

986

6339

E66.01

ICD-10 Finland

Obesity due to excess calories

1.4

38.8

1669

11949

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

38.7

971

6225

RS221, ,

NOMESCO Finland

2.3

38.6

290

1264

L57.0

ICD-10 Finland

Actinic keratosis

1.4

38.6

1918

14081

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

38.5

2041

15141

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

38.5

2372

18017

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.8

38.5

643

3713

F45.0

ICD-10 Finland

Somatization disorder

3.7

38.4

121

328

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

38.4

2940

23044

XKC03

NOMESCO Finland

Water cystometry

1.8

38.3

574

3210

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

38.3

1480

10391

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

2.8

38.3

194

701

SPAT1104

SPAT

Monitoring of emergency patient

1.5

38.2

1227

8304

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.9

38.2

480

2539

K24

ICPC

Fear of heart disease

1.9

38.1

493

2632

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.5

38.1

1274

8695

M01AH02

ATC

rofecoxib; oral

1.3

38.0

2367

18005

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.8

38.0

607

3460

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

37.9

1110

7366

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.6

37.9

1022

6660

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

37.9

5082

42638

J46

ICD-10 Finland

Status asthmaticus

1.8

37.9

546

3018

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.1

37.8

383

1880

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

37.8

1007

6547

SDA03

NOMESCO Finland

Periodontal treatment

1.2

37.7

8230

72479

SPAT1053

SPAT

Memory test

1.3

37.6

2608

20154

G54.0

ICD-10 Finland

Brachial plexus disorders

1.9

37.6

476

2524

F13

ICPC

Eye sensation abnormal

1.8

37.6

552

3068

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

37.6

4226

34761

K29

ICPC

Cardiovascular sympt/complt other

1.6

37.5

796

4900

R07.2

ICD-10 Finland

Precordial pain

2.0

37.5

410

2068

L60.0

ICD-10 Finland

Ingrowing nail

1.6

37.5

904

5742

C05AA08

ATC

fluocortolone; rectal, topical

1.3

37.5

2575

19872

PD5AD

NOMESCO Finland

CT of aorta

2.0

37.5

389

1926

R04.2

ICD-10 Finland

Haemoptysis

1.8

37.4

604

3452

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.4

37.4

2274

17238

F04

ICPC

Visual floaters/spots

3.6

37.3

123

344

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.9

37.2

470

2490

J01MA06

ATC

norfloxacin; oral

1.3

37.2

2448

18776

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

37.1

1086

7206

Angiography of the heart and coronary arteries

1.6

37.1

999

6510

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.3

36.9

287

1270

R03BB04

ATC

tiotropium bromide; inhalant

1.4

36.8

1792

13105

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

2.8

36.8

182

649

N76.0

ICD-10 Finland

Acute vaginitis

1.5

36.7

1173

7931

R06AX22

ATC

ebastine; oral

1.3

36.7

3305

26455

R63.4

ICD-10 Finland

Abnormal weight loss

1.7

36.6

708

4256

N06AX03

ATC

mianserin; oral

1.6

36.5

864

5464

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.6

36.5

798

4951

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.8

36.5

553

3104

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

36.4

3535

28558

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

36.4

1209

8240

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

36.4

8121

71604

R06AX13

ATC

loratadine; oral

1.3

36.3

2896

22810

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.4

36.3

1411

9915

EB1VA, ,

NOMESCO Finland

1.3

36.2

2353

18007

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.6

36.2

777

4797

F32.1

ICD-10 Finland

Moderate depressive episode

1.5

36.2

1094

7310

G36.9

ICD-10 Finland

Acute disseminated demyelination, unspecified

6.3

36.2

L11

ICPC

Wrist symptom/complaint

1.4

36.1

1732

12635

N06AX22

ATC

agomelatine; oral

1.9

36.1

434

2263

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

3.8

36.0

110

292

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.7

36.0

630

3685

S01EA05

ATC

brimonidine; ophthalmic

1.9

35.9

450

2380

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.8

35.8

594

3422

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

3.1

35.8

153

503

XCW10

NOMESCO Finland

Assessment of vision

2.3

35.7

274

1205

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.1

35.6

319

1495

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.5

35.6

1021

6748

S01EC04

ATC

brinzolamide; ophthalmic

1.7

35.5

699

4220

A46

ICD-10 Finland

Erysipelas

1.3

35.5

2677

20920

H57.0

ICD-10 Finland

Anomalies of pupillary function

3.3

35.5

136

419

D07AA02

ATC

hydrocortisone; topical

1.3

35.5

2720

21305

H02.3

ICD-10 Finland

Blepharochalasis

1.5

35.4

1193

8152

R44.1

ICD-10 Finland

Visual hallucinations

3.5

35.4

121

347

R20.0

ICD-10 Finland

Anaesthesia of skin

2.8

35.4

174

619

F34.1

ICD-10 Finland

Dysthymia

1.7

35.4

670

4005

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

35.4

1309

9112

C08CA05

ATC

nifedipine; systemic

1.5

35.3

1097

7372

S00.0

ICD-10 Finland

Superficial injury of scalp

1.9

35.3

436

2294

N05CD07

ATC

temazepam; oral

1.4

35.3

2066

15562

K05

ICPC

Irregular heartbeat other

1.8

35.3

588

3393

R33

ICD-10 Finland

Retention of urine

1.5

35.2

1315

9168

I34.1

ICD-10 Finland

Mitral (valve) prolapse

1.9

35.2

475

2572

R5599

NOMESCO Finland

Other rehabilitation service

1.8

35.1

515

2863

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.5

35.0

968

6345

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.6

34.9

937

6100

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

34.9

7326

64174

R41.3

ICD-10 Finland

Other amnesia

1.8

34.8

531

2985

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

34.8

1252

8668

EB1AA, ,

SPAT

1.5

34.7

1226

8455

D07AC13

ATC

mometasone; topical

1.2

34.7

5722

48981

H35.7

ICD-10 Finland

Separation of retinal layers

2.6

34.7

194

738

M02AA10

ATC

ketoprofen; topical

1.3

34.6

3000

23881

M89.0

ICD-10 Finland

Algoneurodystrophy

2.7

34.5

181

666

S22

ICPC

Nail symptom/complaint

1.5

34.5

1202

8270

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.5

34.5

1173

8032

EBA10

NOMESCO Finland

Operative extraction of tooth

1.3

34.4

2466

19136

P99

ICPC

Psychological disorders other

1.8

34.3

528

2978

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.5

34.3

1106

7492

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.6

34.2

913

5938

XCD20

NOMESCO Finland

Photoangiography of eye

2.2

34.1

299

1389

K02

ICPC

Pressure/tightness of heart

1.9

34.1

433

2299

L09

ICPC

Arm symptom/complaint

1.6

34.1

901

5845

WZC30

NOMESCO Finland

Teaching

1.3

34.1

2967

23625

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.6

34.0

769

4809

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.6

34.0

720

4430

PA7DG

NOMESCO Finland

Very extended MRI examination of vessesl in brain and neck with high intensity magnet

6.7

33.9

R5110, ,

SPAT

1.5

33.9

1194

8233

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

33.8

1509

10869

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.3

33.8

259

1139

N64.4

ICD-10 Finland

Mastodynia

1.7

33.8

601

3533

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.8

33.8

466

2542

WX400

NOMESCO Finland

Inhalation anesthesy

1.6

33.6

782

4924

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

3.4

33.6

119

349

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.5

33.6

1031

6912

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.6

33.5

733

4547

SPAT1283

SPAT

Restricted health certificate

1.3

33.5

3340

27050

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

33.4

1256

8770

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

2.7

33.4

176

650

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.4

33.3

1287

9029

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

2.6

33.3

186

707

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

2.6

33.2

185

702

R1260

NOMESCO Finland

Evaluation of communicative skills

2.1

33.2

297

1391

XX3DW

NOMESCO Finland

Time consuming IT work

1.4

33.1

1943

14637

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.6

33.1

792

5022

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

4.7

33.0

163

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

2.2

33.0

293

1369

L04AG12

ATC

ofatumumab; parenteral

9.1

33.0

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

1.8

32.9

538

3087

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.3

32.9

237

1015

R29

ICPC

Respiratory symptom/complaint other

1.5

32.9

1248

8727

Z31.5

ICD-10 Finland

Genetic counselling

1.5

32.9

960

6367

J01DA06

ATC

[U] cefuroxime

1.3

32.9

2688

21225

R06AE09

ATC

levocetirizine; oral

1.3

32.9

2743

21717

H26.02

ICD-10 Finland

Presenil cataract

1.8

32.8

484

2694

SBB10

NOMESCO Finland

Dental impressions

1.4

32.8

1318

9313

R06.2

ICD-10 Finland

Wheezing

1.6

32.8

821

5261

UJD02

NOMESCO Finland

Gastroscopy

1.6

32.8

845

5451

M75.8

ICD-10 Finland

Other shoulder lesions

1.6

32.7

685

4203

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.4

32.7

1263

8860

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.3

32.6

251

1106

U71

ICPC

Cystitis/urinary infection other

1.4

32.6

1268

8907

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.8

32.6

490

2744

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

32.6

2308

17872

H35.8

ICD-10 Finland

Other specified retinal disorders

3.2

32.6

127

396

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.5

32.5

1239

8670

R30.0

ICD-10 Finland

Dysuria

1.6

32.5

774

4902

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.6

32.5

842

5440

SPAT1043

SPAT

Audiometry

1.4

32.4

1893

14249

R39.1

ICD-10 Finland

Other difficulties with micturition

1.7

32.4

540

3118

R10.2

ICD-10 Finland

Pelvic and perineal pain

1.8

32.3

446

2433

C03DA01

ATC

spironolactone; oral

1.3

32.3

2150

16499

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

32.3

1181

8201

I49.5

ICD-10 Finland

Sick sinus syndrome

1.7

32.3

654

3980

R01AD05

ATC

budesonide; nasal

1.4

32.3

1374

9814

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

32.2

2107

16129

L04AA06

ATC

mycophenolic acid; systemic

2.0

32.2

352

1778

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.9

32.1

404

2139

M35.7

ICD-10 Finland

Hypermobility syndrome

2.2

32.1

272

1247

N05BE01

ATC

buspirone; oral

1.8

32.1

511

2910

L95

ICPC

Osteoporosis

1.7

32.1

655

3993

J01FA01

ATC

erythromycin; systemic

1.3

32.1

2598

20487

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.5

32.0

942

6257

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

3.3

32.0

122

375

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

31.9

1064

7253

D03

ICPC

Heartburn

1.7

31.9

658

4022

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

31.9

2424

18949

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

31.9

738

4642

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.0

31.9

339

1695

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

1.7

31.8

567

3334

N02CC04

ATC

rizatriptan; oral

1.5

31.8

1002

6753

GEC24

NOMESCO Finland

Thoracoscopic thymectomy

6.7

31.8

X18

ICPC

Breast pain female

2.1

31.7

300

1436

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.5

31.7

1070

7312

UDM02

NOMESCO Finland

Sinoscopy

1.9

31.7

402

2134

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.4

31.7

1536

11217

Q21.11

ICD-10 Finland

Paten or persistent foramen ovale

3.3

31.6

118

358

H05.2

ICD-10 Finland

Exophthalmic conditions

4.5

31.6

173

M05BX04

ATC

denosumab; parenteral

1.5

31.6

1070

7319

N06BA04

ATC

methylphenidate; oral

1.7

31.5

579

3433

N06AB05

ATC

paroxetine; oral

1.5

31.4

1062

7260

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.7

31.4

587

3498

G40

ICD-10 Finland

Epilepsy

2.6

31.4

185

723

N06AG02

ATC

moclobemide; oral

1.6

31.3

762

4851

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

2.2

31.3

255

1151

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

3.3

31.2

117

356

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

31.2

1771

13268

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.8

31.2

491

2789

N06AX05

ATC

trazodone; oral

1.8

31.1

463

2586

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.4

31.1

1542

11307

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

31.1

21068

202878

R03AC13

ATC

formoterol; inhalant

1.5

31.0

890

5881

Z50.1

ICD-10 Finland

Other physical therapy

1.5

31.0

956

6415

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

31.0

2306

17974

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.5

30.9

876

5772

XG410

NOMESCO Finland

Flow-volume spirometry

1.6

30.9

700

4380

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

2.9

30.9

144

498

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.4

30.9

1199

8419

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.3

30.9

1951

14855

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

30.9

1353

9711

H35.4

ICD-10 Finland

Peripheral retinal degeneration

2.7

30.8

160

587

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

30.7

1666

12393

SPAT1255

SPAT

Intravenous administration of medicine

1.4

30.7

1214

8554

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.2

30.7

270

1258

L04AA52

ATC

[U] ofatumumab; parenteral

10.3

30.6

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.6

30.5

751

4793

R15

ICD-10 Finland

Faecal incontinence

1.7

30.5

513

2970

M50.3

ICD-10 Finland

Other cervical disc degeneration

1.8

30.4

433

2385

H81.0

ICD-10 Finland

Ménière disease

1.8

30.4

436

2407

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

2.0

30.4

322

1608

G04BD04

ATC

oxybutynin; oral, transdermal

1.5

30.4

923

6174

D68.8

ICD-10 Finland

Other specified coagulation defects

2.3

30.4

219

939

F61.0

ICD-10 Finland

Mixed personality disorders

2.1

30.4

306

1501

WX702

NOMESCO Finland

Supraglottic ventilation device

1.5

30.3

1021

6975

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

30.2

1426

10366

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.5

30.2

1030

7053

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

2.6

30.2

170

649

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

30.2

1784

13445

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

4.6

30.2

151

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

1.9

30.2

353

1825

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.4

30.2

1225

8673

J01MA14

ATC

moxifloxacin; systemic

1.4

30.2

1579

11678

M01AB55

ATC

diclofenac, combinations; oral

1.4

30.1

1179

8292

H06.2

ICD-10 Finland

Dysthyroid exophthalmos

5.4

30.1

110

D35.31

ICD-10 Finland

Cyst in Rathke's pocket

5.5

30.1

103

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

2.9

30.0

136

463

F16

ICPC

Eyelid symptom/complaint

1.5

30.0

937

6303

F80.1

ICD-10 Finland

Expressive language disorder

2.5

30.0

183

727

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.0

30.0

320

1603

I63

ICD-10 Finland

Cerebral infarction

2.7

29.9

156

573

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.6

29.9

626

3842

D07AD01

ATC

clobetasol; topical

1.3

29.8

3137

25536

AA5PD

NOMESCO Finland

CT examination of brain pefusion

2.6

29.8

178

700

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.6

29.8

653

4054

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

1.7

29.8

494

2849

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.4

29.7

1650

12316

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

29.7

2040

15718

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

29.6

5930

51562

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.4

29.6

1729

13009

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

1.6

29.5

792

5156

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

29.4

1412

10293

N03AB02

ATC

phenytoin; systemic

2.4

29.4

201

842

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

29.4

4057

34025

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.6

29.4

747

4805

L29.9

ICD-10 Finland

Pruritus, unspecified

1.7

29.3

490

2831

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

2.6

29.3

175

688

280

Kela drug reimbursment

Clopidogrel

2.2

29.3

241

1093

SPAT1234

SPAT

Support of social functional capacity

1.5

29.3

890

5955

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

29.2

1559

11564

A23

ICPC

Risk factor NOS

1.4

29.2

1582

11762

L03AB13

ATC

peginterferon beta-1a; parenteral

7.4

29.2

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.5

29.1

1043

7213

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.5

29.1

855

5679

C01BC04

ATC

flecainide; systemic

1.6

29.0

608

3733

A02BA04

ATC

nizatidine; systemic

1.4

28.9

1292

9303

J35.0

ICD-10 Finland

Chronic tonsillitis

1.5

28.9

916

6180

S08

ICPC

Skin colour change

1.5

28.9

967

6597

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.7

28.9

546

3263

F27

ICPC

Fear of eye disease

2.4

28.9

195

812

SPAT1211

SPAT

Application of soft bandage

1.4

28.8

1670

12549

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

3.4

28.8

101

295

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.5

28.7

1070

7456

S70.0

ICD-10 Finland

Contusion of hip

1.6

28.7

668

4209

G04CB01

ATC

finasteride; oral

1.4

28.7

1698

12799

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.6

28.7

703

4485

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

1.9

28.6

378

2035

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

28.6

4680

39911

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

28.6

2382

18838

T74.1

ICD-10 Finland

Physical abuse

2.0

28.5

329

1694

N06

ICPC

Sensation disturbance other

2.3

28.4

207

892

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

2.7

28.4

153

572

S06

ICPC

Rash localized

1.5

28.4

1051

7314

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.5

28.3

944

6436

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

2.4

28.2

195

821

S09.9

ICD-10 Finland

Unspecified injury of head

2.1

28.2

268

1287

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.4

28.1

1245

8950

WX882

NOMESCO Finland

High dependency care

1.7

28.1

503

2964

D07AB08

ATC

desonide; topical

1.3

28.1

2006

15540

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.3

28.0

1728

13104

E000001, ,

ATC

1.2

28.0

3864

32386

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.5

28.0

1019

7068

H66.9

ICD-10 Finland

Otitis media, unspecified

1.4

27.9

1196

8548

GD1AD

NOMESCO Finland

Thorax CT examination

1.5

27.9

991

6840

H26.2

ICD-10 Finland

Complicated cataract

2.2

27.9

228

1031

H51.8

ICD-10 Finland

Other specified disorders of binocular movement

9.4

27.9

S01ED01

ATC

timolol; ophthalmic

1.6

27.9

584

3585

K03.00

ICD-10 Finland

Approximal wear

1.4

27.9

1237

8896

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.7

27.8

522

3114

H81

ICPC

Excessive ear wax

1.3

27.8

3148

25825

SPAT1101

SPAT

Orthostatic test

1.6

27.8

739

4803

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.6

27.8

674

4289

-1, ,

ICPC

1.6

27.8

675

4298

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

2.8

27.7

136

484

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.2

27.7

3229

26575

37001

ICD-8 Finland

Refractive errors, Hypermetropia. Hyperopia

8.1

27.7

K03.80

ICD-10 Finland

Irradiated enamel

1.5

27.7

947

6491

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.4

27.6

1208

8666

SPAT1058

SPAT

PEF monitoring instruction

1.4

27.6

1501

11166

I67.0

ICD-10 Finland

Dissection of cerebral arteries, nonruptured

5.0

27.6

119

N06AA12

ATC

doxepin; systemic

1.5

27.6

882

5963

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

2.2

27.5

232

1063

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

1.7

27.5

466

2704

4AA23, ,

NOMESCO Finland

7.3

27.5

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.5

27.5

859

5782

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

2.6

27.4

154

588

H81.4

ICD-10 Finland

Vertigo of central origin

2.6

27.3

151

572

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.8

27.3

393

2174

L50.0

ICD-10 Finland

Allergic urticaria

1.7

27.1

476

2791

T85.2

ICD-10 Finland

Mechanical complication of intraocular lens

3.3

27.1

102

312

N02CC03

ATC

zolmitriptan; nasal, oral

1.5

27.1

932

6396

F41.8

ICD-10 Finland

Other specified anxiety disorders

1.7

27.0

541

3284

D01AE16

ATC

amorolfine; topical

1.3

27.0

2106

16510

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.5

26.9

814

5441

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

1.6

26.9

682

4385

PD5BD

NOMESCO Finland

Extensive CT of aorta

1.9

26.9

312

1610

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.3

26.9

1977

15373

D21

ICPC

Swallowing problem

2.1

26.8

259

1251

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.6

26.8

559

3429

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.4

26.8

1016

7103

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

2.6

26.8

155

601

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

26.7

4967

42830

VALMI, ,

NOMESCO Finland

1.2

26.7

4853

41761

PA7CG

NOMESCO Finland

Extended MRI examination of vessesl in brain and neck with high intensity magnet

5.5

26.7

H82

ICPC

Vertiginous syndrome

1.9

26.7

321

1677

L19

ICPC

Muscle symptom/complaint NOS

1.7

26.6

496

2954

IGY99

NOMESCO Finland

Other psychiatric treatment contact

1.8

26.6

366

1996

H53.6

ICD-10 Finland

Night blindness

96.8

26.6

D64.9

ICD-10 Finland

Anaemia, unspecified

1.3

26.6

1845

14231

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.7

26.6

465

2723

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.6

26.6

670

4303

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

26.5

4524

38704

R49.01

ICD-10 Finland

Functional dysphonia

1.7

26.5

524

3172

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.5

26.4

970

6739

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

2.8

26.4

128

453

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

1.8

26.4

410

2321

SPAT1262

SPAT

Handing over of treatment supplies

1.2

26.4

3213

26563

D16

ICPC

Rectal bleeding

1.8

26.4

430

2469

DFF59

NOMESCO Finland

Other assessment of balance

2.3

26.3

190

816

XQ802

NOMESCO Finland

Epicutan test

1.5

26.3

713

4654

J01DC02

ATC

cefuroxime; systemic

1.5

26.3

973

6771

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

2.1

26.2

249

1196

H51.9

ICD-10 Finland

Disorder of binocular movement, unspecified

10.4

26.2

E000006, ,

ATC

1.4

26.2

1221

8858

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.6

26.1

615

3887

C10AC01

ATC

colestyramine; oral

1.7

26.1

489

2918

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

3.4

26.1

270

B02.9

ICD-10 Finland

Zoster without complication

1.4

26.1

1148

8246

L50.9

ICD-10 Finland

Urticaria, unspecified

1.6

26.0

682

4419

R01AD11

ATC

triamcinolone; nasal

1.3

26.0

1554

11728

J34.2

ICD-10 Finland

Deviated nasal septum

1.5

26.0

864

5888

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.6

26.0

146

558

TKC22

NOMESCO Finland

Catheterisation instruction

1.8

26.0

377

2092

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

3.6

25.9

233

Y94.8

ICD-10 Finland

Other leisure activity accident

1.7

25.9

489

2923

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

3.1

25.9

107

346

M01AX01

ATC

nabumetone; oral

1.5

25.9

730

4807

R10.0

ICD-10 Finland

Acute abdomen

1.6

25.9

581

3630

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

1.9

25.9

345

1864

XA402

NOMESCO Finland

ENMG

1.7

25.9

427

2460

N27

ICPC

Fear of neurological disease other

2.0

25.9

287

1459

N05AX08

ATC

risperidone; systemic

1.4

25.8

1402

10424

AA9CW, ,

NOMESCO Finland

4.8

25.8

122

CAC10

NOMESCO Finland

Reconstruction of orbital wall using bone graft or plate

4.3

25.8

150

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.5

25.8

863

5887

I20.00

ICD-10 Finland

Unstable angina

1.7

25.8

461

2716

A13

ICPC

Concern/fear medical treatment

1.9

25.7

333

1783

B80

ICPC

Iron deficiency anaemia

1.7

25.7

436

2532

S01EE03

ATC

bimatoprost; ophthalmic

1.8

25.7

384

2150

WX720

NOMESCO Finland

Own respiration

1.5

25.6

820

5545

A10AB05

ATC

insulin aspart; parenteral

1.4

25.6

1314

9682

PA2AC

NOMESCO Finland

Cerebral angiography with X-ray

3.3

25.6

298

EMAK, ,

NOMESCO Finland

1.6

25.5

649

4179

E66.8

ICD-10 Finland

Other obesity

1.4

25.4

956

6673

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.6

25.4

618

3936

G71.3

ICD-10 Finland

Mitochondrial myopathy, not elsewhere classified

7.3

25.4

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1.7

25.4

448

2631

R2110

NOMESCO Finland

Giving the first information

1.4

25.3

1207

8786

H15.1

ICD-10 Finland

Episcleritis

2.0

25.3

265

1319

RD210, ,

NOMESCO Finland

1.9

25.3

330

1770

A03CA02

ATC

clidinium and psycholeptics; oral

1.4

25.3

988

6945

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

1.8

25.3

388

2189

K04.09

ICD-10 Finland

Pulpit UNS

1.5

25.3

764

5106

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.6

25.3

673

4376

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

3.1

25.3

106

346

J45.8

ICD-10 Finland

Mixed asthma

1.6

25.3

535

3295

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

25.2

3373

28151

M77.4

ICD-10 Finland

Metatarsalgia

1.4

25.2

1053

7493

N99

ICPC

Neurological disease other

2.1

25.2

224

1049

-60

ICPC

Result test/procedure

1.4

25.2

1042

7404

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.3

25.1

1777

13741

H3603, E103,

ICD-10 Finland

2.4

25.1

172

723

SGC10

NOMESCO Finland

Pulp capping

1.3

25.1

1552

11775

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

2.6

25.0

149

586

H40.11

ICD-10 Finland

Low pressure glaucoma

1.8

25.0

370

2065

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.3

25.0

2027

15964

PA2YT

NOMESCO Finland

Cerebral artery PTA with stent

4.3

25.0

150

F41.00

ICD-10 Finland

Moderate panic disorder

2.0

24.9

283

1450

N03

ICPC

Pain face

2.4

24.9

176

749

P01BA02

ATC

hydroxychloroquine; oral

1.3

24.9

1488

11228

D10

ICPC

Vomiting

1.4

24.9

1082

7753

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.0

24.9

284

1458

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

1.5

24.8

683

4474

N88

ICPC

Epilepsy

2.8

24.8

123

441

SPAT1009

SPAT

Measurement of intraocular pressure

2.0

24.7

248

1216

J01

ICD-10 Finland

Acute sinusitis

1.4

24.7

971

6833

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.4

24.7

1362

10151

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.5

24.7

906

6294

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

2.4

24.7

164

679

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.8

24.7

390

2219

J02AC02

ATC

itraconazole; systemic

1.2

24.7

3255

27125

A10AE04

ATC

insulin glargine; parenteral

1.3

24.7

1630

12482

F03

ICPC

Eye discharge

1.4

24.6

1202

8786

B02AA02

ATC

tranexamic acid; systemic

1.3

24.6

2665

21737

XCH05

NOMESCO Finland

Eye pressure longterm registration

2.4

24.6

172

729

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.6

24.5

633

4087

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.2

24.5

3765

31860

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

24.4

1262

9311

D82

ICPC

Teeth/gum disease

1.2

24.4

7455

66898

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.5

24.4

741

4959

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.3

24.4

1701

13127

A06AC51

ATC

ispaghula, combinations; oral

1.5

24.3

856

5899

H21.0

ICD-10 Finland

Hyphaema

3.4

24.3

248

N19

ICPC

Speech disorder

2.1

24.3

236

1143

M01AX05

ATC

glucosamine; oral

1.2

24.3

3544

29832

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.5

24.3

670

4392

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.3

24.2

1572

12005

K99

ICPC

Cardiovascular disease other

1.7

24.2

446

2649

H03BB01

ATC

carbimazole; oral

1.5

24.2

717

4773

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

2.6

24.2

142

555

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

24.1

2517

20440

-50

ICPC

Medication/prescr/renewal

1.5

24.1

699

4631

CBJ40

NOMESCO Finland

Resection of levator muscle of eyelid

2.6

24.1

133

504

S10

ICPC

Boil/carbuncle

1.4

24.1

1008

7176

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

3.5

24.0

231

S12

ICPC

Insect bite/sting

1.3

24.0

1483

11246

C10AA04

ATC

fluvastatin; oral

1.3

24.0

1438

10856

S90.3

ICD-10 Finland

Contusion of other and unspecified parts of foot

1.7

24.0

443

2635

TFP20

NOMESCO Finland

Cardiodefibrillation

1.4

23.9

1190

8724

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.5

23.9

832

5722

SXC05

NOMESCO Finland

Other oral or dental procedure

1.4

23.9

1228

9054

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.6

23.8

514

3181

A60

ICPC

General and Unspecified, Result test/procedure

1.5

23.8

761

5145

F02.89*G35

ICD-10 Finland

Dementia in multiple sclerosis

5.2

23.8

3780A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Convergent concomitant strabismus[STRABISMUS CONCOMITANS CONVERGENS]

5.2

23.8

H81.9

ICD-10 Finland

Disorder of vestibular function, unspecified

2.1

23.8

221

1053

S01EE05

ATC

tafluprost; ophthalmic

1.6

23.8

596

3823

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.3

23.8

1482

11252

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

23.8

523

3253

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.2

23.8

3949

33658

H33.2

ICD-10 Finland

Serous retinal detachment

4.1

23.7

156

S06.3

ICD-10 Finland

Focal brain injury

2.1

23.7

216

1022

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

1.9

23.7

275

1421

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.4

23.7

887

6188

104

Kela drug reimbursment

Thyroid insufficiency

1.4

23.6

1263

9367

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.5

23.6

743

5008

L04AX03

ATC

methotrexate; systemic

1.3

23.6

1734

13474

N80

ICPC

Head injury other

1.8

23.6

341

1891

K83

ICPC

Heart valve disease NOS

2.3

23.6

180

793

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.5

23.6

754

5100

G91.0

ICD-10 Finland

Communicating hydrocephalus

2.9

23.5

106

361

RS222, ,

NOMESCO Finland

2.1

23.5

215

1019

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

1.6

23.5

553

3497

G83.4

ICD-10 Finland

Cauda equina syndrome

3.1

23.5

304

H91.9

ICD-10 Finland

Hearing loss, unspecified

1.5

23.4

802

5500

PA2AG

NOMESCO Finland

Restrected MRI examination of vessels in the head with high intensity magnet

4.0

23.4

162

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

1.8

23.4

353

1983

N02CC06

ATC

eletriptan; oral

1.6

23.3

590

3794

R25.3

ICD-10 Finland

Fasciculation

3.0

23.3

326

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.0

23.3

257

1305

A10AC01

ATC

insulin (human); parenteral

1.4

23.3

1241

9201

S97

ICPC

Chronic ulcer skin

1.4

23.3

1003

7178

F32

ICD-10 Finland

Depressive episode

1.4

23.2

957

6795

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

1.9

23.2

274

1425

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

3.5

23.1

218

A06AX04

ATC

linaclotide; oral

3.3

23.0

267

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

1.7

23.0

468

2854

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.0

22.9

250

1264

3684A

ICD-9 Finland

Visual disturbances, Visual field defects[HOMONYYMIT NÄKÖKENTTÄPUUTOKSET]

+∞

22.9

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.6

22.9

564

3604

H35.9

ICD-10 Finland

Retinal disorder, unspecified

2.8

22.9

110

388

N02CC05

ATC

almotriptan; oral

1.5

22.9

657

4345

U04

ICPC

Incontinence urine

1.4

22.9

903

6362

L04AE01

ATC

fingolimod; oral

7.3

22.9

R04

ICPC

Breathing problem other

1.5

22.8

646

4259

H26.9

ICD-10 Finland

Cataract, unspecified

1.9

22.8

273

1426

I65.0

ICD-10 Finland

Occlusion and stenosis of vertebral artery

4.0

22.8

161

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.3

22.8

1438

10940

G03DB01

ATC

dydrogesterone; oral

1.3

22.8

2219

17873

D01AC02

ATC

miconazole; topical

1.4

22.7

1270

9485

37301

ICD-8 Finland

Strabismus, Concomitans divergens

2.3

22.7

175

774

CA1AE

NOMESCO Finland

Eye and orbita ultrasound examination

3.1

22.7

300

R3120

NOMESCO Finland

Training in mobility skills

3.4

22.7

245

F44.7

ICD-10 Finland

Mixed dissociative [conversion] disorders

5.5

22.7

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.5

22.6

788

5421

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.3

22.6

1714

13373

N02CD03

ATC

fremanezumab; systemic

2.4

22.6

159

676

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.6

22.6

561

3591

CKC15

NOMESCO Finland

Panretinal photocoagulation

2.5

22.6

141

568

C07AB12

ATC

nebivolol; oral

1.6

22.6

486

3008

R08

ICPC

Nose symptom/complaint other

1.5

22.5

600

3904

P25

ICPC

Phase of life problem adult

1.5

22.5

742

5050

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

3.2

22.5

276

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.0

22.5

240

1205

TQW99

NOMESCO Finland

Other minor procedure on skin

1.4

22.5

854

5975

L04AA40

ATC

cladribine; oral

7.4

22.4

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.5

22.4

765

5241

R19.5

ICD-10 Finland

Other faecal abnormalities

1.9

22.4

289

1546

M15

ICD-10 Finland

Polyarthrosis

1.4

22.4

854

5976

U13

ICPC

Bladder symptom/complaint other

1.6

22.4

507

3176

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

1.3

22.4

1913

15160

SPAT1252

SPAT

Overall medication plan or its review

1.4

22.2

1161

8582

CKC10

NOMESCO Finland

Local photocoagulation of retina

1.9

22.1

277

1468

CA1DG

NOMESCO Finland

Eye and orbita very extensive MRI examination with high intensity magnet

5.2

22.1

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.1

22.1

8892

81230

G83.9

ICD-10 Finland

Paralytic syndrome, unspecified

4.5

22.1

118

G91.1

ICD-10 Finland

Obstructive hydrocephalus

3.2

22.1

269

K86

ICPC

Hypertension uncomplicated

1.3

22.0

2214

17896

ACC51

NOMESCO Finland

Release of median nerve

1.3

22.0

1294

9743

A01AB04

ATC

amphotericin B; local oral

1.5

21.9

771

5314

K59.01

ICD-10 Finland

Constipation outlet obstruction type

2.1

21.9

208

1000

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

1.9

21.9

266

1396

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.4

21.8

1185

8811

N06BA07

ATC

modafinil; oral

3.2

21.8

261

-69

ICPC

Other reason for encounter NEC

1.5

21.8

664

4447

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.5

21.8

644

4286

K28

ICPC

Limited function/disability (K)

1.8

21.8

345

1967

S02

ICPC

Pruritus

1.5

21.8

639

4247

K11.2

ICD-10 Finland

Sialoadenitis

1.6

21.7

567

3672

A07AA09

ATC

vancomycin; oral

2.0

21.7

244

1247

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

1.8

21.7

329

1851

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

1.7

21.7

402

2395

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

1.7

21.7

372

2170

X57

ICD-10 Finland

Unspecified privation

1.7

21.6

391

2314

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

2.0

21.6

244

1250

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

21.6

465

2879

R19.4

ICD-10 Finland

Change in bowel habit

1.6

21.6

473

2941

K01

ICPC

Heart pain

2.0

21.6

234

1182

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.4

21.5

903

6432

L10

ICPC

Elbow symptom/complaint

1.4

21.5

885

6282

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

1.7

21.5

397

2363

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

1.7

21.4

365

2124

Z29

ICPC

Social problem NOS

1.7

21.4

369

2154

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.5

21.4

601

3956

PA2AE

NOMESCO Finland

Ultrasound examination of brain artery

6.2

21.4

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

3.1

21.3

285

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

2.6

21.2

124

484

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.4

21.2

798

5571

-62

ICPC

Administrative procedure

1.6

21.2

477

2984

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.0

21.2

227

1141

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

1.9

21.2

249

1293

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

2.3

21.1

151

648

R20.1

ICD-10 Finland

Hypoaesthesia of skin

2.6

21.1

120

463

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

1.9

21.1

266

1415

K03.66

ICD-10 Finland

Tooth plaque

1.3

21.0

1321

10041

N06AA06

ATC

trimipramine; systemic

1.7

21.0

394

2354

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.3

21.0

1919

15331

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

1.9

21.0

249

1297

XX7FW, ,

NOMESCO Finland

4.8

21.0

R47.1

ICD-10 Finland

Dysarthria and anarthria

2.3

21.0

158

693

PA7CC

NOMESCO Finland

Very extensive angiography of arteries of neck and brain

4.8

21.0

S15

ICPC

Foreign body in skin

1.4

21.0

1104

8170

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

2.6

20.9

117

447

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.4

20.9

1167

8714

S19

ICPC

Skin injury other

1.5

20.9

668

4519

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3037467) Urinalysis macro (dipstick) panel - Urine

17681

145253

1.72

320.67

5.4

4.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

23646

213811

2.57

316.83

21.8

15.7

3.95

3.96

mmol/l

4.24

23270

207811

(3006504) Eosinophils/100 leukocytes in Blood

12920

98187

1.64

313.97

7.1

6.1

2.83

2.85

0.32

12196

91696

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

19286

162745

1.77

312.92

4.9

4.0

14.74

14.76

pmol/l

0.41

17780

147998

(3019069) Monocytes/100 leukocytes in Blood

12974

98770

1.64

312.51

7.5

6.4

8.58

8.52

1.21

12251

92404

(3022096) Basophils/100 leukocytes in Blood

12580

95117

1.64

310.75

7.1

6.1

0.68

0.15

11842

88585

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2859

13730

2.22

308.77

2.5

2.3

24.78

23.10

au/ml

0.26

150

1078

(3018418) pH of Serum or Plasma

8785

60697

1.68

308.40

4.4

4.0

7.40

0.09

1489

11628

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1329

4220

3.27

307.65

1.5

1330.94

2592.35

e6/l

0.58

1081

3444

(3031040) Bacteria [#/volume] in Urine by Automated count

17149

139374

1.71

307.65

5.7

4.4

1115.70

1531.51

e6/l

0.48

180

1917

(3006315) Basophils [#/volume] in Blood

13895

104729

1.72

307.65

7.0

5.9

0.04

e9/l

0.39

12172

90559

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

19290

159432

1.88

307.65

8.5

7.4

76.67

78.21

u/l

5.38

18305

150074

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1331

4214

3.28

307.65

1.4

1.5

22.68

32.34

e6/l

0.46

1039

3260

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

708

1373

5.28

307.65

1.1

264.00

256.92

mg/l

0.14

635

1205

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6423

38405

1.90

307.65

4.6

3.6

366.02

467.11

ng/l

0.93

4738

29317

(3013826) Glucose [Moles/volume] in Serum or Plasma

16762

120386

2.16

307.65

5.7

4.6

6.50

6.69

mmol/l

26.32

15955

111958

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1529

4757

3.36

307.65

1.3

1.4

503.01

510.09

mg/l

0.15

1457

4528

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1362

4186

3.38

307.65

1.3

3.67

3.73

mmol/l

1.31

1270

3939

(3044290) Cell count panel - Cerebral spinal fluid

1293

3908

3.43

307.65

1.4

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

736

1426

5.29

307.65

1.2

43.82

41.55

mg/l

0.25

633

1183

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

11147

59734

2.55

307.65

2.5

2.1

164.05

208.99

u/l

2.55

10666

55805

(40760892) CBC W Ordered Manual Differential panel - Blood

13082

98547

1.68

307.65

7.3

6.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

13519

93282

1.96

307.65

16.9

14.3

1.30

1.25

inr

0.92

3887

27322

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

13948

106854

1.68

307.65

6.3

6.1

10.92

11.33

umol/l

4.15

13208

101147

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

14161

102395

1.87

307.65

7.6

6.5

1.21

1.22

mmol/l

1.79

12310

86657

(3013115) Eosinophils [#/volume] in Blood

14255

108203

1.72

307.65

7.2

6.1

0.19

e9/l

1.55

12631

94866

(3013707) Erythrocyte sedimentation rate by Westergren method

19195

154424

2.00

307.65

4.9

4.0

11.45

12.11

mm/h

9.07

18059

142693

(3013650) Neutrophils [#/volume] in Blood by Automated count

15442

120894

1.71

307.65

9.8

9.0

4.06

4.10

e9/l

1.71

13609

105493

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

11118

75570

1.84

307.65

4.4

3.5

71.17

64.03

ng/l

0.10

7510

50279

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

691

1312

5.39

307.65

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6626

29992

2.64

307.65

2.4

2.1

29.47

29.81

4.73

6446

29070

(3019550) Sodium [Moles/volume] in Serum or Plasma

23633

213257

2.59

307.65

21.6

15.6

139.63

139.64

mmol/l

0.20

23309

207669

(3033658) Prothrombin time (PT) actual/Normal

7989

51985

1.78

307.65

4.4

3.9

90.89

90.45

0.81

7809

50669

(3019198) Lymphocytes [#/volume] in Blood

14112

107775

1.70

307.65

7.0

5.9

1.89

1.94

e9/l

3.39

12589

95345

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

772

839

9.46

307.65

1.1

3.64

6.53

nmol/l

0.64

174

159

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

13073

92747

1.85

307.65

6.8

5.9

1.21

mmol/l

1.78

12097

84434

(3001604) Monocytes [#/volume] in Blood

13862

104492

1.72

307.65

6.9

5.9

0.58

e9/l

2.21

12155

90443

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

23397

210209

2.46

307.65

19.1

13.7

21.09

23.51

mg/l

26.41

19349

165743

(3024561) Albumin [Mass/volume] in Serum or Plasma

11977

88719

1.66

307.65

5.1

4.8

35.93

35.54

g/l

12.26

11169

82346

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

22048

193361

2.07

307.65

5.9

4.7

1.93

2.08

mu/l

0.83

20585

177583

(3018010) Neutrophils/100 leukocytes in Blood

13063

100157

1.63

301.32

7.0

5.9

57.12

57.11

0.02

12364

93862

(3002030) Lymphocytes/100 leukocytes in Blood

13204

101708

1.62

297.20

7.2

6.1

27.98

28.10

0.65

12495

95410

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

6906

45137

1.73

295.09

2.1

1.7

1.07

1.23

mg/l

3.79

5166

34400

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

11260

83791

1.62

289.15

2.1

2.0

96.75

96.22

pmol/l

0.55

5864

43496

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

583

1108

5.36

289.06

1.6

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2631

12554

2.22

287.60

1.4

1.3

41.22

51.84

au/ml

1.36

636

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

738

1716

4.40

287.50

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

521

947

5.60

271.19

1.1

1.04

1.05

u/l

0.10

238

428

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

8009

56124

1.62

254.05

3.3

3.0

1245.49

1389.18

ng/l

2.49

6826

47936

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

8941

65003

1.58

239.54

3.0

2.5

57.58

63.70

u/l

2.21

8258

59931

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3349

18790

1.90

231.66

2.4

2.2

367.35

376.41

nmol/l

1.40

3080

17253

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

11237

86768

1.53

225.39

2.5

2.3

76.60

1127.39

nmol/l

0.50

10162

78083

(3020564) Creatinine [Moles/volume] in Serum or Plasma

23887

221402

2.36

225.26

21.5

15.8

77.01

76.03

umol/l

4.22

23881

221326

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

21026

187658

1.70

212.50

6.3

5.6

39.47

39.51

mmol/mol

0.25

19678

173490

(36304419) Bacteria [Presence] in Urine

7786

55997

1.56

212.45

3.7

3.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5066

32840

1.68

211.98

3.6

3.4

0.82

mmol/l

4.12

4736

30646

(3018095) Leukocytes [#/volume] in Urine

9754

73770

1.52

211.16

4.5

3.7

74.66

97.94

e6/l

1.86

7160

51388

(3030467) Casts [#/volume] in Urine by Automated count

7940

57457

1.56

210.32

3.8

3.1

0.32

0.42

e6/l

4.55

6227

43415

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

237

236

10.13

209.93

1.2

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

9256

69429

1.52

207.16

3.2

3.4

2.35

2.36

mmol/l

6.15

8072

60982

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

238

244

9.84

206.43

1.0

—

(3044889) 12 lead EKG panel

16783

142443

1.53

206.28

4.4

3.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

16270

137648

1.51

199.02

3.6

3.0

45.76

46.76

u/l

0.73

15312

128332

(3002582) Erythrocytes [#/volume] in Urine

8444

62652

1.52

196.06

3.9

3.2

54.98

95.55

e6/l

3.03

6678

47645

(3001122) Ferritin [Mass/volume] in Serum or Plasma

11688

92696

1.48

195.90

3.2

2.9

114.93

121.49

ug/l

1.81

10839

85955

(3021960) Folate [Moles/volume] in Serum or Plasma

6673

47136

1.56

193.43

1.6

1.5

20.43

20.46

nmol/l

0.05

5780

40328

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2916

16528

1.86

192.96

2.7

2.3

7.09

7.04

ug/l

0.04

2506

14337

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4931

32429

1.65

192.69

2.0

1.8

—

(3026008) Bacteria identified in Urine by Culture

8666

64877

1.51

191.74

3.6

3.0

—

(3023368) Bacteria identified in Blood by Culture

7473

54343

1.53

189.03

4.7

4.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

7225

52220

1.54

187.71

2.5

2.3

2.79

2.94

mg/l

6.55

6216

44596

(3005719) IgG [Mass/volume] in Serum or Plasma

2739

15346

1.88

187.64

2.7

2.8

10.26

10.52

g/l

2.39

2496

14091

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5232

35203

1.61

185.46

3.2

2.7

1.06

1.23

e6/l

0.81

3058

19898

(3023410) Appearance of Cerebral spinal fluid

663

1951

3.46

184.72

1.5

1.7

—

(40761511) CBC panel - Blood by Automated count

23470

218510

1.99

178.87

17.6

12.9

—

(3016018) Differential panel - Cerebral spinal fluid

676

2059

3.35

178.34

1.4

1.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

23760

222365

2.09

175.40

13.0

10.1

25.78

25.96

u/l

0.64

23117

214414

(3000850) Epithelial cells [#/volume] in Urine

6146

43467

1.55

173.79

3.0

2.6

5.45

5.93

e6/l

2.24

5562

38793

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1706

8316

2.13

173.17

1.9

39.04

39.17

u/l

0.09

1528

7353

(3036489) Thrombin time

1592

7595

2.17

170.71

2.4

2.1

21.10

21.60

2.16

1378

6610

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8830

67607

1.47

169.01

3.5

3.2

31.08

33.56

u/l

3.34

8369

64011

(3037522) Nuclear Ab [Titer] in Serum

4318

28386

1.63

166.03

1.4

518.69

546.98

titre

0.46

884

5908

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

6558

47446

1.52

165.41

1.3

1.95

1.67

u/ml

0.64

1557

12656

(3007164) IgA [Mass/volume] in Serum or Plasma

5820

41100

1.54

164.12

1.6

1.5

2.25

2.38

g/l

5.60

3374

24761

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

21815

199693

1.66

163.59

5.0

4.4

5.90

mmol/l

0.03

20127

182501

(3003396) Base excess in Arterial blood by calculation

3564

22422

1.69

162.39

7.5

7.1

1.10

1.05

mmol/l

0.40

2830

17906

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3554

22430

1.68

159.78

7.5

7.1

5.06

5.09

kpa

0.85

3373

21418

(3027801) Oxygen [Partial pressure] in Arterial blood

3550

22419

1.68

159.16

7.5

7.1

12.77

12.46

kpa

2.58

3374

21396

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

5173

35814

1.56

158.74

1.3

30.27

36.55

iu/ml

1.68

1515

11385

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3504

22107

1.68

157.55

1.9

1.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

6637

48808

1.49

152.18

4.3

3.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3491

22215

1.66

151.35

1.9

1.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

5366

37795

1.53

151.22

1.8

1.7

1132.86

1168.77

nmol/l

2.09

4134

28462

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4774

32822

1.56

149.97

3.4

2.9

3.31

2.98

e6/l

1.19

2614

17649

(3015736) pH of Urine

10441

83843

1.42

148.60

4.0

3.4

5.92

5.89

0.42

666

6260

(3035350) Ketones [Presence] in Urine by Test strip

12511

103707

1.41

148.15

4.4

3.6

0.00

estimate

1.72

2327

20972

(3009261) Glucose [Presence] in Urine by Test strip

12617

104803

1.41

147.24

4.4

3.7

0.01

0.00

estimate

0.85

2170

19418

(40758558) Short blood count panel - Blood

7055

52885

1.46

145.41

7.3

6.9

—

(3021601) Nitrite [Presence] in Urine by Test strip

12475

103756

1.40

142.59

5.9

4.9

0.00

estimate

3.51

2227

19847

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

21284

195208

1.56

140.67

17.0

12.8

82.36

82.11

ml/min/173m2

0.92

18186

160223

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

498

1459

3.46

139.60

1.3

1.90

2.09

mmol/l

3.46

451

1369

(3026782) Osmolality of Urine

5704

41319

1.49

138.67

3.3

2.9

535.83

540.37

mosm/kgh2o

0.80

4951

35350

(3013247) Albumin in CSF/Albumin in Serum or Plasma

231

373

6.24

135.91

1.1

7.18

6.79

mg/g

0.15

221

355

(40768797) Stomach Pathology biopsy report

4158

28274

1.56

135.52

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

11927

99007

1.39

134.85

2.8

2.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3942

26534

1.58

134.20

6.3

5.7

1.05

mmol/l

0.10

3693

24668

(3016502) Oxygen saturation in Arterial blood

3141

20014

1.65

134.18

8.1

7.5

95.92

95.67

1.36

3019

19265

(3009542) Hematocrit [Volume Fraction] of Blood

24440

233656

2.27

131.21

28.4

20.3

40.07

40.18

1.05

22937

218985

(3007461) Platelets [#/volume] in Blood

24442

233835

2.25

128.40

28.2

20.2

251.65

253.03

e9/l

2.63

24060

227572

(3035941) MCH [Entitic mass]

24448

233981

2.25

127.19

28.1

20.1

30.25

30.24

0.35

24255

230615

(3010813) Leukocytes [#/volume] in Blood

24452

234044

2.25

127.02

28.2

20.2

6.76

6.73

e9/l

1.41

23995

227067

(3024731) MCV [Entitic volume]

24449

234004

2.25

127.02

28.1

20.1

90.86

90.84

0.45

24258

230629

(3026361) Erythrocytes [#/volume] in Blood

24449

234027

2.24

126.60

28.2

20.2

4.48

4.49

e12/l

2.84

23988

227084

(3000963) Hemoglobin [Mass/volume] in Blood

24450

234093

2.24

125.63

28.4

20.3

134.48

134.92

g/l

5.18

24260

230755

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2909

18463

1.65

125.61

8.4

7.9

122.03

121.04

g/l

1.90

2819

17967

(3048689) Calprotectin [Mass/mass] in Stool

3861

26243

1.56

125.03

2.2

2.3

126.50

131.15

ug/g

0.23

3006

20604

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4753

33845

1.50

123.66

1.3

10.87

12.55

u/ml

0.75

1610

13079

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

137

133

10.35

123.56

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

8378

66287

1.39

122.92

2.6

2.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

501

1602

3.17

121.92

2.5

2.3

17.86

19.82

nmol/l

3.70

481

1514

(3022948) Iron [Moles/volume] in Serum or Plasma

4606

32691

1.50

121.49

2.7

2.5

13.06

13.14

umol/l

0.31

4267

30423

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

15653

136999

1.37

121.24

3.4

3.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5155

37462

1.47

120.74

2.8

3.0

2.44

2.45

mmol/l

9.44

4460

32719

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

22201

207240

1.57

117.69

5.5

4.7

2.67

2.76

mmol/l

50.74

20677

191411

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

21104

194920

1.49

117.16

4.4

3.8

1.29

1.28

mmol/l

1.97

19498

178653

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

539

1850

2.96

115.99

1.6

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

21859

203580

1.53

114.49

5.0

4.3

4.54

4.67

mmol/l

68.88

20426

188914

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2934

19098

1.61

113.59

2.8

2.5

44.07

47.32

u/l

0.10

2512

16343

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

21691

201971

1.51

110.67

4.9

4.2

1.45

1.47

mmol/l

21.75

20174

186540

(3014111) Lactate [Moles/volume] in Serum or Plasma

2718

17475

1.62

110.51

7.7

6.9

1.28

1.36

mmol/l

3.59

2655

17016

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4232

30126

1.49

108.53

2.7

2.5

2.37

2.34

g/l

1.59

3887

27828

(3002385) Erythrocyte distribution width [Ratio]

19895

182546

1.42

106.60

22.3

16.3

14.86

14.98

1.06

19691

179265

(40768804) Tissue Pathology biopsy report

10248

85070

1.34

106.27

2.2

2.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

6510

50381

1.39

105.24

2.5

2.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3969

28167

1.49

102.74

2.8

2.5

22.30

22.65

0.83

3316

24060

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2343

14808

1.64

101.59

1.7

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1227

6413

1.96

101.49

2.7

2.4

95.30

91.71

7.01

1161

6149

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2569

16664

1.60

100.10

3.3

2.8

178.65

200.54

ng/l

2.01

2334

15210

(36660697) Celiac disease serology panel - Serum

2619

17111

1.59

98.93

1.2

—

(3021589) Normoblasts [#/volume] in Blood

11030

93227

1.32

98.30

11.0

9.5

0.00

e9/l

0.35

9012

76432

(3013512) EKG study

7334

58425

1.36

97.47

4.4

3.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

3501

24466

1.50

97.26

1.9

1.8

—

(3012544) pH of Venous blood

2900

19490

1.55

96.68

4.9

4.0

7.37

7.38

0.53

142

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3332

23103

1.51

96.04

4.2

237.79

244.06

u/l

1.56

3131

21803

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3374

23466

1.51

95.81

2.7

2.8

6.95

8.36

umol/l

4.19

2891

20258

(3002032) Base excess in Venous blood by calculation

2807

18811

1.55

94.65

5.0

4.0

1.89

1.88

mmol/l

0.04

2409

15987

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

151

230

6.60

94.12

2.5

2.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2809

18864

1.55

93.77

4.9

4.0

5.86

5.83

kpa

0.66

2723

18321

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1451

8217

1.81

93.39

1.3

1.2

0.78

0.93

u/ml

0.20

126

722

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

706

3080

2.33

93.26

1.3

1.2

4.63

3.77

u/ml

0.47

265

1052

(3000991) Gas panel - Venous blood

2596

17158

1.57

92.95

9.3

8.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1526

8800

1.78

92.39

1.5

12.94

14.42

u/ml

0.14

241

(3020630) Protein [Mass/volume] in Serum or Plasma

2499

16407

1.58

92.06

2.5

2.6

66.61

66.44

g/l

0.57

2270

14875

(3028026) IgM [Mass/volume] in Serum or Plasma

1949

12039

1.67

92.01

2.0

1.9

1.31

1.33

g/l

0.19

1782

10969

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2113

13363

1.63

90.90

3.4

3.3

4.44

4.48

pmol/l

1.12

1898

11867

(3019150) Specific gravity of Urine by Refractometry

5835

45275

1.38

90.26

4.8

4.0

1.02

kg/l

1.08

815

6996

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1119

5906

1.94

89.75

2.9

2.6

179.44

188.29

2.75

1060

5582

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

680

2980

2.32

88.88

1.3

1.2

4.22

3.94

u/ml

0.22

329

1325

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1193

6456

1.89

88.69

1.9

1.7

1.20

1.17

g/l

2.30

1139

6130

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1165

6257

1.90

88.64

1.9

1.7

0.23

g/l

0.10

1106

5918

(3026493) Urate [Moles/volume] in Serum or Plasma

6714

53387

1.35

88.44

2.8

2.6

3004.07

4548.16

umol/l

3.32

5788

46676

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6722

53531

1.35

87.47

1.7

1.6

1.37

1.36

mmol/l

0.84

5807

44900

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2341

15332

1.58

86.88

4.0

3.8

89.46

88.94

ng/l

0.08

2064

13194

(3019060) Gas panel - Arterial blood

2031

12898

1.62

85.70

5.2

4.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1874

11732

1.65

83.66

1.8

1.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1690

10305

1.69

83.53

9.3

24.41

24.31

mmol/l

0.66

1627

9973

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1934

12239

1.63

82.65

7.4

6.9

24.61

24.59

mmol/l

0.11

1835

11652

(3020779) Urea [Moles/volume] in Serum or Plasma

2613

17832

1.52

80.19

8.0

7.2

8.89

9.69

mmol/l

7.60

2470

16975

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

636

2840

2.27

79.51

1.1

121.87

117.61

2.44

580

2543

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

5141

39849

1.36

78.22

1.7

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1717

10689

1.65

78.19

9.9

9.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1007

5370

1.91

78.17

2.0

11.35

10.96

mg/l

0.35

930

4993

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1966

12703

1.59

76.87

8.3

7.1

24.74

24.82

mmol/l

0.49

1955

12579

(3024354) Oxygen [Partial pressure] in Venous blood

2312

15523

1.54

76.33

4.3

3.4

4.64

4.58

kpa

0.64

2240

15015

(3005322) IgE [Units/volume] in Serum or Plasma

2020

13174

1.58

75.86

1.4

1.3

237.93

234.78

u/ml

0.04

1864

12137

(3004588) Protein electrophoresis panel - Serum or Plasma

2048

13424

1.57

75.23

2.4

2.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1195

6809

1.79

75.03

2.4

2.3

310.89

567.61

ug/l

3.96

1124

6353

(3014007) Fractional oxyhemoglobin in Arterial blood

1915

12365

1.59

75.03

9.5

9.0

94.13

93.94

0.73

1910

12316

(3009508) Creatinine [Moles/volume] in Urine

7726

63822

1.30

75.02

3.4

3.2

7.38

7.51

mmol/l

1.72

6528

53932

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

320

1049

3.08

74.74

1.6

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

297

937

3.20

74.02

1.2

1.3

59.87

67.26

0.56

100

(3000494) Fungus identified in Specimen by Culture

3297

23904

1.44

73.98

1.6

1.4

—

(3042936) Bacteria identified in Isolate by Culture

3858

28809

1.40

73.16

2.2

2.0

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1901

12335

1.58

72.86

9.5

8.9

1.38

1.37

0.07

1894

12254

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

252

735

3.45

71.27

1.1

1073.17

438.63

ng/l

0.61

176

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

321

1085

2.98

71.08

1.1

—

(3047181) Lactate [Moles/volume] in Blood

1114

6325

1.80

70.72

6.0

5.7

1.28

1.31

mmol/l

0.30

996

5590

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

315

1057

3.01

70.66

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1270

7508

1.73

70.06

2.1

1.6

341.57

309.57

mu/l

0.66

1161

6776

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

485

2046

2.40

69.15

2.5

2.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1424

8722

1.67

68.84

1.1

40.40

7.10

u/ml

0.64

123

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1185

6904

1.75

68.83

1.6

194.35

268.20

titre

0.59

300

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1580

9950

1.63

68.45

5.3

4.4

24.22

24.13

mmol/l

0.65

1552

9742

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

603

2816

2.17

67.53

1.2

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

627

2994

2.12

66.32

1.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

3114

22784

1.42

65.79

2.5

2.6

1.75

1.76

0.33

2749

20134

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1001

5637

1.81

65.25

1.4

1.5

25.16

14.23

iu/ml

0.67

132

(40761535) Cells panel - Urine sediment

2388

16657

1.48

65.08

4.1

3.4

—

(3003338) MCHC [Mass/volume]

19213

179156

1.30

65.06

24.9

17.5

332.37

332.31

g/l

0.40

19101

177796

(3003327) Ova and parasites identified in Stool by Light microscopy

1203

7191

1.71

63.64

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

923

5173

1.81

61.10

2.2

1.8

4.40

11.90

iu/l

0.94

346

1874

(4200892) Spirometry reversibility

2138

14800

1.49

60.31

1.5

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

5380

43374

1.31

59.92

1.7

44782571.11

32917765.13

pmol/l

0.59

4475

35817

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1789

11980

1.53

59.15

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1228

7527

1.66

59.03

2.3

2.2

3.56

3.72

g/l

4.64

1104

6749

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1228

7538

1.66

58.69

2.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1781

11935

1.53

58.67

4.5

3.4

130.06

128.74

g/l

1.72

1728

11658

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1229

7549

1.66

58.59

2.3

2.2

7.29

7.43

g/l

1.92

1106

6760

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1079

6412

1.71

58.26

2.0

1.7

—

(3012516) Albumin [Mass/volume] in Urine

7017

58694

1.27

58.19

3.4

3.3

658.02

409.96

mg/l

2.84

4411

37178

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1051

6206

1.72

58.07

3.4

2.7

3.51

3.58

g/l

0.86

1002

5900

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

468

2101

2.25

57.81

1.1

95.32

94.70

0.19

439

1960

(3019225) pH of Specimen

2757

20184

1.41

57.49

4.5

4.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1159

7057

1.67

57.13

2.3

2.2

9.93

10.18

g/l

1.13

1030

6230

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3334

25237

1.37

56.82

8.5

6.8

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1158

7081

1.67

56.14

2.2

2.3

2.85

2.95

g/l

2.76

1035

6293

(3023511) Choriogonadotropin [Units/volume] in Urine

801

4414

1.84

56.00

1.5

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

979

5728

1.74

55.89

1.3

29.08

40.18

u/ml

0.71

350

(3009466) Valproate [Moles/volume] in Serum or Plasma

564

2765

2.06

55.66

4.4

5.0

358.36

365.87

umol/l

0.55

485

2380

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

150

363

4.15

55.59

1.3

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1272

7986

1.62

55.54

5.6

5.0

0.91

0.89

0.74

1185

7487

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

345

1379

2.52

55.37

2.7

2.6

0.24

0.23

e9/l

0.48

296

1177

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

324

1257

2.60

55.31

1.7

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1286

8116

1.62

54.96

5.5

5.0

1.73

1.66

1.39

1195

7611

(3025941) Bacteria identified in Stool by Culture

1767

12002

1.51

54.49

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

1047

6293

1.69

54.16

3.2

3.1

—

(3011412) CD3 cells [#/volume] in Blood

440

1979

2.24

54.13

2.5

2.4

1.30

1.18

e9/l

2.07

391

1755

(3014148) Varicella zoster virus Ab [Titer] in Serum

543

2654

2.07

54.03

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1618

10813

1.53

53.85

2.4

—

(3023520) Reticulocytes [#/volume] in Blood

2354

16952

1.43

53.65

2.4

2.6

69.19

69.67

e9/l

0.26

1792

12742

(3039000) Anion gap in Blood

783

4354

1.82

53.16

7.1

6.7

11.08

11.19

mmol/l

0.42

702

3915

(3018572) Chloride [Moles/volume] in Blood

783

4355

1.82

53.12

7.1

6.7

105.21

105.11

mmol/l

0.22

702

3916

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

9200

80044

1.23

52.38

4.7

3.8

—

(3022145) Colonoscopy Study observation

3056

23109

1.37

52.05

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1050

6384

1.67

51.99

1.6

12.93

7.91

iu/ml

0.20

219

1400

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1002

6018

1.69

51.97

1.4

293.81

272.87

ug/g

1.51

573

3490

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

344

1427

2.43

51.01

2.7

2.5

486.28

515.75

e6/l

0.65

291

1179

(3020682) Albumin/Creatinine [Ratio] in Urine

7264

61742

1.25

50.89

3.9

3.8

9.28

9.27

mg/mmol

0.01

4436

38789

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2050

14636

1.44

48.78

1.2

130.58

144.36

iu/ml

0.92

768

5483

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

749

4238

1.79

47.99

1.2

42.17

45.17

u/ml

0.19

416

(3017143) Hepatitis C virus Ab [Presence] in Serum

3211

24768

1.34

47.70

1.7

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

996

6109

1.66

47.64

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

4927

40277

1.28

47.57

2.0

1.9

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

987

6056

1.66

47.14

1.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1389

9248

1.53

46.89

4.0

2.9

1.24

1.26

0.26

1380

9203

(3029937) Albumin [Presence] in Urine by Test strip

6609

55985

1.24

46.88

5.0

4.0

0.00

estimate

0.93

2168

19144

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1849

13056

1.45

46.62

4.0

3.7

5.12

5.14

kpa

0.57

1749

12366

(42529406) Shigella sp [Presence] in Stool by Culture

993

6124

1.65

46.48

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

354

1556

2.29

46.07

2.2

2.1

14.53

14.86

0.23

344

1515

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

882

5295

1.69

45.79

1.3

9.40

8.28

u/ml

0.20

127

851

(3009343) pH of Capillary blood

1824

12897

1.45

45.62

4.0

3.7

7.42

0.07

213

1665

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

911

5522

1.67

45.60

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1025

6422

1.62

45.03

2.4

0.76

0.89

g/l

0.64

891

5467

(1175426) CD3 cells/100 lymphocytes in Blood

356

1587

2.26

44.82

2.2

2.1

73.97

72.46

1.10

344

1521

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1353

9056

1.52

44.52

4.0

2.9

0.65

0.14

1347

9023

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

866

5217

1.68

44.37

1.3

7.59

5.94

u/ml

0.34

558

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1909

13700

1.43

43.97

2.5

2.1

11.98

11.91

nmol/l

0.13

1707

12223

(3035637) Corticotropin [Mass/volume] in Plasma

502

2583

1.96

43.32

1.6

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1041

6618

1.60

43.04

3.9

3.1

0.36

0.35

u/ml

0.27

610

3770

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

180

584

3.10

43.00

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

946

5879

1.63

42.94

2.2

38.13

37.70

g/l

1.46

823

5078

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1756

12475

1.44

42.73

4.0

3.7

1.44

1.75

mmol/l

3.01

1272

9214

(3024928) Oxygen saturation in Venous blood

716

4143

1.75

42.49

4.4

3.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

740

4332

1.73

42.14

1.3

1.2

2.79

4.99

u/ml

0.99

339

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

911

5648

1.64

41.74

2.2

0.02

0.03

g/l

0.27

840

5133

(3013139) Helicobacter pylori Ag [Presence] in Stool

1928

14029

1.41

40.95

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

731

4302

1.72

40.84

1.3

1.2

16.49

12.42

u/ml

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

843

5164

1.65

40.50

2.3

0.00

g/l

-0.00

783

4727

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

478

2481

1.94

40.24

1.9

1.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

852

5243

1.65

40.21

2.3

2.2

0.00

g/l

1.71

784

4744

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1164

7725

1.53

39.79

2.0

1.8

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

225

862

2.62

39.55

2.5

2.3

55.65

51.42

umol/l

1.09

190

744

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1278

8664

1.50

39.49

2.6

2.3

4869.31

5758.90

u/l

0.44

435

3415

(3024980) IgG subclass 4 [Mass/volume] in Serum

595

3342

1.80

39.11

1.7

1.6

0.81

0.76

g/l

0.36

450

2519

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

736

4398

1.69

38.88

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

736

4399

1.69

38.85

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1335

9191

1.48

38.20

1.7

1.51

1.53

g/l

0.42

1146

7845

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

157

510

3.09

37.50

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2165

16333

1.36

36.68

2.8

2.6

65.53

66.13

ml/min/173m2

0.29

909

6432

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2503

19310

1.33

36.47

2.3

0.22

0.21

g/l

1.57

2320

17983

(3006245) CD3-CD19+ cells/100 cells in Blood

214

836

2.57

36.21

2.5

2.3

9.89

11.10

0.58

194

785

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

155

514

3.03

35.75

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

219

872

2.52

35.62

6.6

10.7

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

153

507

3.03

35.34

1.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

1033

6857

1.53

35.25

4.3

4.0

1.32

1.38

mmol/l

1.38

1021

6737

(3027273) Bicarbonate [Moles/volume] in Venous blood

1357

9522

1.45

35.14

4.5

3.4

25.24

mmol/l

0.01

1308

9247

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

448

2385

1.89

35.01

1.7

1468.57

2533.03

titre

0.67

(3000060) B lymphocytes [#/volume] in Blood

172

613

2.82

34.85

2.4

2.3

562.64

394.82

e6/l

0.16

340

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

146

476

3.08

34.70

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

929

6055

1.55

34.45

1.5

1.4

10.54

10.24

u/l

0.25

735

4923

(3049717) Cytology report of Urine Cyto stain

1085

7313

1.51

34.44

2.5

2.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

730

4495

1.64

34.39

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

316

1500

2.12

34.14

2.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1221

8450

1.47

33.98

2.2

2.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1551

11227

1.41

33.78

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

149

501

2.99

33.58

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

681

4161

1.65

33.08

5.6

5.4

355.49

1432.46

iu/ml

1.69

605

(3008898) HLA-B27 [Presence]

1046

7062

1.50

32.93

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1190

8246

1.46

32.89

4.5

4.1

24.57

24.84

mmol/l

2.74

1102

7647

(3028707) Methadone [Presence] in Urine by Screen method

610

3630

1.70

32.77

3.4

2.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

276

1263

2.20

32.74

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2081

15869

1.34

32.68

1.5

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1018

6850

1.51

32.57

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

879

5732

1.55

32.53

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

198

789

2.52

32.21

1.1

—

(3020891) Body temperature

1141

7885

1.47

31.97

5.6

4.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

132

426

3.11

31.96

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

304

1461

2.09

31.83

2.8

2.6

761.13

679.80

e6/l

2.05

299

1401

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3060

24693

1.27

31.43

1.8

1.7

1.47

1.44

2.07

2657

21722

(4062490) Immunoglobulin typing, IgG

400

2131

1.89

31.24

1.6

1.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

178

685

2.61

31.13

2.2

2.6

1.11

1.19

ug/l

0.23

172

647

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

266

1227

2.18

30.97

1.1

1.07

ratio

0.03

451

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

507

2913

1.76

30.93

1.3

4.44

1.26

nmol/l

0.60

493

2790

(3000492) Spirometry study

2555

20202

1.29

30.82

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

507

2917

1.75

30.78

1.3

0.29

0.25

nmol/l

0.21

198

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

199

814

2.46

30.64

2.4

2.2

27.06

29.15

1.41

189

774

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

320

1591

2.02

30.59

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

684

4269

1.62

30.54

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

318

1579

2.03

30.51

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

398

2135

1.88

30.44

1.6

1.4

0.36

0.41

g/l

2.68

298

1478

(3027135) IgG subclass 1 [Mass/volume] in Serum

398

2136

1.88

30.40

1.6

1.4

6.42

6.78

g/l

1.21

297

1477

(3028192) IgG subclass 2 [Mass/volume] in Serum

398

2136

1.88

30.40

1.6

1.4

3.00

2.91

g/l

0.45

297

1482

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

897

5964

1.52

30.38

1.4

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

319

1589

2.02

30.34

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

317

1581

2.02

30.05

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

318

1588

2.02

30.04

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

316

1577

2.02

29.90

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

323

1625

2.00

29.88

1.2

1.1

66.86

50.95

u/ml

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

872

5785

1.53

29.84

2.2

1.8

—

(3022313) Gas panel - Capillary blood

1305

9369

1.41

29.74

4.4

3.9

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

462

2617

1.78

29.61

1.2

72.54

52.55

u/ml

0.69

180

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

161

605

2.67

29.56

1.3

1.2

24.15

20.82

0.22

(3010838) Calcium [Moles/time] in 24 hour Urine

607

3712

1.65

29.42

1.8

1.9

5.27

5.07

mmol/24h

0.47

543

3261

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

982

6697

1.49

29.42

2.8

2.6

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

640

3969

1.63

29.34

1.3

1.2

75.00

166.59

titre

1.65

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

254

1177

2.17

29.27

1.4

1.5

5.80

6.04

u/l

0.11

202

1001

(3045414) Leukocytes [Presence] in Urine

1296

9325

1.41

29.16

2.0

1.9

—

(3023420) DNA double strand Ab [Units/volume] in Serum

403

2205

1.84

28.98

1.7

1.5

28.14

33.69

iu/ml

0.45

109

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

670

4215

1.61

28.97

1.4

17.45

22.43

u/ml

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

674

4247

1.60

28.95

1.5

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

644

4018

1.62

28.82

1.3

276.35

267.12

u/ml

0.30

406

2541

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4011

33681

1.23

28.64

1.7

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

389

2114

1.85

28.59

1.5

1.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

533

3182

1.69

28.34

3.3

2.9

506.45

4663.10

u/ml

0.77

181

(3005988) Vibrio sp identified in Specimen by Organism specific culture

453

2592

1.76

28.07

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

6478

56988

1.18

28.00

5.0

4.9

2.85

3.24

ug/l

0.54

5798

51075

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

452

2589

1.76

27.91

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

456

2627

1.75

27.60

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

450

2589

1.75

27.37

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

579

3566

1.64

27.31

2.0

1.8

189.95

191.87

pmol/l

0.16

549

3381

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

458

2651

1.74

27.27

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

867

5856

1.50

27.25

1.1

5.39

6.81

u/ml

0.49

738

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

463

2692

1.73

27.14

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

453

2621

1.74

27.02

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

916

6268

1.48

26.99

3.3

38.56

43.69

mg/l

0.47

756

5057

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1096

7772

1.43

26.75

2.1

2.0

2.28

2.14

ug/l

0.10

942

6862

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

530

3214

1.66

26.58

1.3

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

807

5410

1.51

26.31

1.2

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

913

6280

1.47

26.21

3.3

41.72

62.65

mg/l

1.58

752

5068

(3003181) Sodium [Moles/volume] in Urine

560

3458

1.63

26.16

1.5

1.4

66.27

63.02

mmol/l

0.97

464

2738

(3017732) Neutrophils [#/volume] in Blood

1871

14496

1.31

26.10

2.7

2.8

4.86

4.92

e9/l

0.07

1438

11658

(40768443) Skin Pathology biopsy report

1262

9215

1.39

26.02

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

613

3884

1.59

25.77

1.4

1.5

111.09

113.73

u/ml

0.21

122

857

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

783

5246

1.51

25.60

1.9

1.7

41.67

42.52

nmol/l

0.40

757

5102

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

443

2601

1.72

25.11

7.0

6.2

11.67

11.74

mg/l

0.10

402

2365

(3020717) Zinc [Moles/volume] in Serum or Plasma

217

1007

2.16

25.00

1.6

1.5

24.53

24.85

umol/l

0.05

203

962

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

231

1099

2.11

24.96

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

646

4175

1.56

24.94

2.5

2.7

30.59

33.89

umol/l

4.37

586

3752

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

881

6107

1.46

24.31

3.2

5.57

4.07

ratio

0.21

486

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3102

25778

1.23

24.11

2.3

2.1

—

(1002224) Polysomnography panel

1104

7992

1.40

23.96

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

197

897

2.21

23.82

1.0

1.1

96.25

96.35

0.01

162

703

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1069

7706

1.40

23.78

1.6

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

470

2847

1.66

23.72

1.9

3.93

6.53

titre

0.45

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

347

1932

1.81

23.67

1.6

1.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

147

591

2.50

23.62

3.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1192

8784

1.37

23.23

5.0

3.9

49.78

48.02

1.63

1182

8694

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2821

23295

1.24

23.22

2.2

2.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

766

5238

1.48

22.69

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

190

873

2.19

22.50

1.7

1.9

2.02

1.92

umol/l

0.76

175

822

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

114

414

2.76

22.49

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

428

2575

1.67

22.21

1.4

1.3

329.37

380.05

pmol/l

0.56

378

2221

(3002179) Metamyelocytes/100 leukocytes in Blood

2014

16095

1.27

22.02

4.3

3.9

0.68

0.69

0.06

708

5088

(3037756) Immunofixation for Serum or Plasma

629

4159

1.53

21.94

1.6

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5165

45345

1.17

21.93

4.4

4.3

22.48

21.95

1.55

2407

22079

(3008295) Osmolality of Serum or Plasma

350

2002

1.76

21.83

1.5

282.20

278.92

mosm/kgh2o

1.86

276

1550

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

196

923

2.13

21.82

1.5

1.6

3.80

11.96

nmol/l

0.71

160

775

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

708

4805

1.49

21.79

1.6

—

(3011985) Renin [Units/volume] in Plasma

451

2766

1.64

21.73

1.7

1.5

62.65

64.40

mu/l

0.06

415

2453

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

227

1132

2.01

21.68

2.9

2.7

42.90

39.33

2.22

151

631

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

335

2.93

21.63

1.8

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1317

9977

1.34

21.45

1.5

1.4

27.38

27.57

iu/l

0.07

1105

8569

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

515

3275

1.58

21.39

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

515

3276

1.58

21.36

1.6

—

(3034426) Prothrombin time (PT)

158

692

2.29

21.04

1.3

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

196

937

2.10

21.01

1.1

1645.10

1493.66

miu/ml

0.98

196

937

(3011048) Pyruvate [Moles/volume] in Blood

115

4.44

20.94

1.5

1.3

79.87

86.79

umol/l

0.55

105

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2982

25018

1.22

20.92

4.9

4.4

32.90

32.56

0.94

2189

17180

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

258

3.19

20.89

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

2174

17646

1.25

20.80

4.5

4.0

1.02

0.93

0.66

778

5892

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

271

1458

1.87

20.72

1.3

1.4

11.62

12.32

umol/l

0.91

262

1374

(3011288) Drugs identified in Urine by Screen method

810

5701

1.43

20.64

4.0

2.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

499

3177

1.58

20.64

1.4

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

914

6578

1.40

20.54

1.4

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1872

14953

1.27

20.51

2.2

1.9

—

(3051651) Icteric interference index of Serum or Plasma

244

1274

1.92

20.45

3.9

3.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1526

11883

1.30

20.42

2.0

1.8

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

155

684

2.27

20.30

3.1

2.9

28.92

28.47

umol/l

0.14

121

517

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

681

4658

1.47

20.18

1.7

1.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

182

3.58

19.89

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

159

716

2.23

19.85

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

906

6566

1.39

19.56

2.9

2.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

209

3.36

19.43

2.1

2.7

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

118

471

2.51

19.35

1.2

95.24

94.44

0.11

118

465

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

253

1362

1.87

19.34

2.9

3.3

151.39

132.27

nmol/l

0.27

248

1340

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

507

3297

1.55

19.14

1.1

21.31

10.87

au/ml

0.80

190

(3016650) Hepatitis A virus Ab [Presence] in Serum

510

3322

1.55

19.11

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

208

1053

1.98

19.11

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1411

10978

1.30

18.99

1.3

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

189

927

2.05

18.97

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

188

924

2.04

18.77

3.0

2.0

159.37

134.09

umol/l

0.37

105

479

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

157

723

2.18

18.59

1.2

0.31

0.30

g/l

0.48

119

587

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

256

3.05

18.56

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

408

2544

1.61

18.47

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

765

5442

1.42

18.41

2.8

2.5

—

(3025159) Blasts/100 leukocytes in Blood

1964

15976

1.25

18.37

4.5

4.1

0.34

0.35

0.02

573

4312

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

151

688

2.20

18.36

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

193

966

2.01

18.34

1.1

9.58

15.28

u/ml

0.42

(3051611) Lipemic interference index of Serum or Plasma

367

2234

1.65

18.30

3.5

3.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1331

10330

1.30

18.25

1.1

221.21

205.16

titre

0.08

263

(3023419) Bacteria identified in Sputum by Culture

459

2955

1.56

18.15

2.6

2.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

257

1429

1.81

17.75

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

147

672

2.19

17.75

1.2

110.87

111.35

0.07

133

598

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

147

672

2.19

17.75

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

255

1418

1.81

17.62

1.2

—

(3022621) pH of Urine by Test strip

1709

13758

1.26

17.49

3.3

2.9

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

485

3192

1.53

17.38

1.5

1.3

25.89

27.04

u/l

0.32

402

2611

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

153

717

2.14

17.37

1.5

1.4

74.02

72.24

1.06

146

685

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

151

704

2.15

17.37

1.5

1.4

643.81

711.17

mu/l

0.12

144

672

(3028433) Virus identified in Specimen by Culture

144

659

2.19

17.35

1.1

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

559

3806

1.48

17.02

1.4

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

2039

16808

1.23

16.84

4.5

4.1

0.13

0.11

0.23

648

5090

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

518

3483

1.50

16.79

1.5

1.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

153

727

2.11

16.78

1.5

1.4

14.36

15.26

pmol/l

1.32

129

606

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

116

492

2.36

16.74

1.3

162.19

126.11

nmol/l

0.75

352

(3033923) Metanephrine [Moles/time] in 24 hour Urine

103

415

2.49

16.63

1.1

13.80

0.65

umol/24h

0.49

196

(21494814) CD8 cells/100 lymphocytes in Specimen

159

770

2.07

16.59

1.9

2.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

206

1093

1.89

16.56

1.5

10.08

8.27

ug/l

0.36

188

995

(3035947) Staphylolysin Ab [Units/volume] in Serum

188

969

1.95

16.48

1.2

1.1

3.00

3.76

iu/ml

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

192

997

1.93

16.47

1.5

2.0

145.93

141.58

0.34

181

926

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

496

3321

1.50

16.42

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1360

10737

1.28

16.35

3.1

2.7

0.23

0.28

e6/l

1.12

1321

10455

(3020191) Ethanol [Moles/volume] in Serum or Plasma

282

1655

1.71

16.20

1.8

1.4

1.20

1.34

promille

0.79

222

1238

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

366

2297

1.60

16.20

1.2

1.1

2.50

2.03

iu/ml

0.25

(3028626) Oxygen [Partial pressure] in Capillary blood

716

5156

1.40

16.11

4.2

3.6

8.56

8.42

kpa

1.37

697

5027

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

482

3231

1.50

15.88

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

259

1493

1.74

15.88

1.3

1.26

1.92

u/ml

0.69

156

837

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

264

2.85

15.83

1.7

1.3

62.87

52.63

1.06

123

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

147

704

2.09

15.82

1.1

87.23

91.09

0.83

309

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

358

2253

1.60

15.68

1.6

1.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

207

3.10

15.68

1.1

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

358

2254

1.60

15.65

1.6

1.5

—

(3038026) Centromere Ab [Units/volume] in Serum

278

1642

1.70

15.62

1.3

1.2

29.45

56.48

u/ml

0.76

(3015235) Bicarbonate [Moles/volume] in Capillary blood

710

5136

1.39

15.57

3.1

3.2

24.52

24.70

mmol/l

0.60

693

5022

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

154

759

2.04

15.37

2.5

2.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

6220

56530

1.13

15.34

3.9

3.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

359

2274

1.59

15.31

3.0

3.3

7.19

9.00

nmol/l

0.23

346

2199

(40760888) Immunoglobulin light chains.free panel - Serum

660

4737

1.40

15.17

3.5

3.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2761

23669

1.19

15.07

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

397

2586

1.54

14.99

1.4

—

(3037121) Protein [Mass/volume] in Urine

944

7189

1.33

14.87

3.1

3.2

0.31

0.32

g/l

0.14

407

3116

(3034770) Mitochondria Ab [Titer] in Serum

768

5671

1.37

14.86

1.2

841.36

971.10

titre

0.25

182

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

165

848

1.95

14.65

1.6

1.9

28.67

28.93

umol/l

0.12

158

821

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

268

1597

1.69

14.61

1.2

73.22

74.63

u/ml

0.03

(3017704) Immunofixation for Urine

193

1046

1.85

14.59

1.5

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2035

17035

1.21

14.39

4.1

3.8

1.22

1.23

mmol/l

3.98

1825

14788

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

268

1604

1.68

14.38

1.2

50.94

40.63

u/ml

0.40

126

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

328

2068

1.59

14.31

1.1

—

(3045424) Erythrocytes [Presence] in Urine

505

3493

1.45

14.26

1.4

1.5

—

(3028271) Lactate [Moles/volume] in Capillary blood

481

3296

1.47

14.26

2.1

1.8

1.68

1.72

mmol/l

0.38

471

3220

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

205

2.98

14.04

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

217

2.91

13.88

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

256

1531

1.68

13.80

1.2

3.00

9.93

u/ml

1.82

105

(3010421) pH of Blood

734

5447

1.36

13.79

4.2

3.8

7.42

0.54

663

4972

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

140

695

2.02

13.75

1.1

88.80

91.12

0.27

313

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

127

3.55

13.72

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

300

1873

1.61

13.66

2.7

2.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

544

3856

1.42

13.48

1.5

1.6

—

(3016879) Cocaine [Presence] in Urine

1012

7891

1.29

13.44

2.9

2.0

—

(21494755) Public health laboratory ask at order entry panel

1647

19836

0.82

13.35

1.3

—

(3036180) Methadone [Presence] in Urine

183

1005

1.83

13.31

3.6

2.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

445

3047

1.47

13.28

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

338

2185

1.55

13.27

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

113

525

2.16

13.24

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

339

2195

1.55

13.22

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

143

728

1.97

13.11

1.1

1.2

111.97

106.85

0.78

131

654

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

622

4536

1.38

13.06

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

237

2.75

12.93

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

243

2.72

12.89

1.0

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

178

980

1.82

12.86

1.1

—

(3027315) Oxygen [Partial pressure] in Blood

649

4778

1.37

12.86

4.1

4.0

8.76

8.64

kpa

0.98

638

4657

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

173

3.07

12.86

1.1

1.0

—

(3012501) Base excess in Blood by calculation

645

4745

1.37

12.84

4.2

3.9

2.17

2.55

mmol/l

3.69

438

3211

(3013290) Carbon dioxide [Partial pressure] in Blood

645

4747

1.37

12.81

4.2

3.9

5.00

kpa

0.14

634

4627

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

138

3.34

12.80

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

4017

35855

1.14

12.77

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

761

5748

1.33

12.75

1.2

1.3

118.49

136.67

titre

0.31

531

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

405

2748

1.48

12.68

1.6

1.5

—

(21491868) Cryoglobulin [Mass/volume] in Serum

138

703

1.97

12.65

1.4

1.2

0.80

0.25

g/l

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

751

5669

1.33

12.63

4.8

4.2

1.52

1.51

mg/l

0.19

688

5202

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

493

3478

1.43

12.58

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

786

5980

1.32

12.53

1.8

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

434

2994

1.46

12.49

1.4

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

3.78

12.40

1.0

1.1

2.74

3.23

u/l

—

(3026250) Tacrolimus [Mass/volume] in Blood

161

871

1.85

12.33

43.1

34.3

7.37

7.24

ug/l

0.33

150

787

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

273

1712

1.60

12.26

1.2

290.00

121.69

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

273

1715

1.60

12.17

1.2

168.54

191.19

titre

0.17

320

(40767503) Oxygen content in Capillary blood by calculation

600

4404

1.37

12.14

2.6

2.5

16.73

16.30

1.52

297

2280

(3024869) Neuronal Ab [Presence] in Serum

335

2.39

12.02

1.2

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

221

1327

1.67

11.82

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

296

1910

1.56

11.78

4.0

3.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

621

4606

1.36

11.77

1.4

1.6

—

(3016244) Insulin [Units/volume] in Serum or Plasma

224

1355

1.66

11.65

3.3

24.71

27.31

mu/l

0.53

213

1273

(3000764) Benzodiazepines [Presence] in Urine

1062

8486

1.26

11.62

2.8

2.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

374

2545

1.48

11.59

2.3

2.0

23.81

26.01

mg/l

0.33

101

686

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

224

1357

1.66

11.59

1.1

8.84

8.10

iu/ml

0.14

323

(3002079) Sodium [Moles/time] in 24 hour Urine

165

928

1.78

11.18

1.3

1.2

150.38

159.25

mmol/24h

0.78

165

928

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

130

3.23

11.17

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

431

3036

1.43

11.15

1.3

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

194

2.79

11.10

1.1

8.51

1.61

umol/24h

0.51

194

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

415

2906

1.44

11.09

1.6

1.5

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

240

2.59

11.04

3.3

3.2

42.60

41.35

umol/l

0.16

204

(4035726) Immunohistochemistry procedure

2115

18205

1.18

10.90

1.4

—

(3003694) ABO and Rh group [Type] in Blood

6466

59858

1.11

10.82

1.4

1.5

—

(3028300) Cannabinoids [Presence] in Urine

1062

8564

1.25

10.76

2.8

2.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

183

1073

1.71

10.74

2.9

1.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2395

20851

1.16

10.69

3.7

3.3

—

(3027008) Opiates [Presence] in Urine

1056

8544

1.25

10.40

2.6

1.9

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

321

2168

1.49

10.38

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

264

1718

1.54

10.19

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

264

1718

1.54

10.19

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

264

1718

1.54

10.19

1.5

1.6

—

(3027944) Amphetamines [Presence] in Urine

1038

8405

1.25

10.15

2.7

1.9

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

253

1634

1.55

10.11

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

428

3067

1.40

10.09

1.2

1.3

35.09

35.72

u/l

0.03

372

2659

(1761868) Lipid panel - Serum or Plasma

6792

72813

0.91

10.04

2.9

2.8

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

109

3.31

9.95

1.1

1.0

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

205

1265

1.63

9.94

1.9

2.3

102.14

96.46

1.76

191

1178

(3027456) Digoxin [Moles/volume] in Serum or Plasma

507

3750

1.36

9.87

3.4

3.1

0.78

0.81

nmol/l

0.79

395

2893

(3044927) Protein electrophoresis panel - Urine

288

1924

1.50

9.86

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

624

4768

1.32

9.74

2.2

130.92

129.07

g/l

0.98

432

3488

(3020911) Cortisol [Moles/time] in 24 hour Urine

129

704

1.84

9.72

1.5

1.4

100.92

149.28

nmol/24h

0.84

129

704

(3018133) Calcium [Moles/volume] in Urine

375

2.16

9.71

2.0

2.1

2.70

2.54

mmol/l

0.27

336

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3617

32593

1.13

9.70

3.0

0.74

0.77

ug/l

0.83

2499

21689

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

334

2309

1.45

9.63

2.4

2.5

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

140

787

1.78

9.58

2.1

66.96

62.81

ug/l

0.23

135

768

(1616796) Gas panel - Central venous blood

609

4650

1.32

9.57

3.7

3.6

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

186

1132

1.65

9.55

1.3

1.2

174.30

348.45

u/l

3.66

172

1045

(3042517) Benzodiazepines panel - Urine

246

2.44

9.54

2.7

2.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

447

3265

1.38

9.44

1.7

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

473

2.01

9.42

1.1

1.2

—

(4146454) Self-monitoring of blood glucose

310

2125

1.46

9.36

2.8

2.7

—

(3014271) Vancomycin [Susceptibility]

168

1004

1.68

9.27

3.1

2.9

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

141

2.91

9.19

1.3

1.1

9.38

28.18

1.74

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

141

2.91

9.19

1.8

1.4

27.69

36.13

0.58

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

126

696

1.81

9.16

1.4

1.9

52976.83

31265.15

u/ml

0.16

(3036603) Volume of Urine

213

1355

1.58

9.15

1.6

1.5

2078.47

1907.68

0.74

208

1315

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

564

4297

1.32

9.03

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

2463

21756

1.15

8.97

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

915

7414

1.24

8.94

1.9

—

(3002256) Pathology report gross observation

3062

27443

1.13

8.93

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

535

4055

1.33

8.89

1.7

—

(3021901) Oxygen saturation in Capillary blood

498

3739

1.34

8.83

2.7

2.9

—

(40757494) Bilirubin.total [Moles/volume] in Blood

176

1084

1.63

8.67

2.1

2.2

16.69

40.10

umol/l

2.62

113

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

383

2770

1.39

8.63

1.5

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

195

1234

1.58

8.60

1.2

—

(3016038) Potassium [Moles/volume] in Urine

206

1322

1.56

8.55

1.3

1.2

32.66

34.97

mmol/l

0.73

175

1127

(3017354) Segmented neutrophils/100 leukocytes in Blood

294

2044

1.44

8.30

3.9

3.2

56.44

56.87

0.12

243

1722

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

301

2.20

8.28

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

186

1176

1.59

8.25

12.1

12.0

0.59

0.62

mmol/l

0.94

164

1085

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

185

2.54

8.19

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

252

1706

1.48

8.17

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

265

2.27

8.13

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

138

813

1.70

8.09

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

398

2931

1.36

8.06

2.1

2.2

6.35

7.13

umol/l

0.22

292

2157

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

133

778

1.71

8.01

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

490

1.90

7.91

1.5

1.3

16.99

16.89

umol/l

0.07

435

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

154

2.67

7.86

1.1

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

216

1433

1.51

7.76

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

271

2.22

7.73

1.6

1.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

316

2259

1.40

7.69

4.0

3.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

318

2278

1.40

7.64

1.6

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

3.42

7.64

1.3

1.6

0.40

0.07

u/l

0.81

(3008536) Aspergillus sp Ab [Presence] in Serum

385

2.00

7.64

1.9

2.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

839

6873

1.23

7.47

1.3

203.86

224.26

miu/ml

0.94

359

3178

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

321

2.09

7.47

1.2

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

166

1048

1.59

7.46

1.5

1.6

1.23

1.22

nmol/l

0.04

120

824

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.06

7.40

5.0

4.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

674

5399

1.26

7.37

1.4

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

4.13

7.26

1.8

1.5

159.69

234.19

nmol/l

0.88

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

173

2.49

7.21

1.6

1.01

1.92

mg/l

0.77

116

(3028717) Thiamine [Mass/volume] in Blood

204

2.36

7.15

1.2

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

434

3300

1.32

7.15

1.3

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

168

2.50

7.13

1.6

2.10

1.65

mg/l

0.29

117

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

168

2.50

7.13

1.6

0.97

1.94

mg/l

1.44

106

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

168

2.50

7.13

1.6

0.66

1.22

mg/l

0.84

113

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

168

2.50

7.13

1.6

2.02

2.14

mg/l

0.04

106

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

168

2.50

7.13

1.6

2.67

4.36

mg/l

1.05

107

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

168

2.50

7.13

1.6

1.34

1.27

mg/l

0.04

108

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

168

2.50

7.13

1.6

1.57

3.11

mg/l

1.50

113

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

168

2.50

7.13

1.6

1.76

2.51

mg/l

0.51

112

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

168

2.50

7.13

1.6

1.32

2.32

mg/l

1.14

125

(3004809) Band form neutrophils/100 leukocytes in Blood

436

3319

1.32

7.13

3.6

3.3

1.51

1.53

0.05

381

2964

(3045716) Anion gap in Serum or Plasma

143

882

1.62

7.10

2.4

2.6

9.57

9.83

mmol/l

0.37

137

861

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

107

2.90

6.98

1.2

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

4.36

6.95

1.8

1.5

337.92

329.29

nmol/l

0.02

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

212

1438

1.48

6.89

1.5

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

131

797

1.65

6.88

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

544

4288

1.27

6.84

1.1

1.12

2.19

u/ml

4.52

305

2197

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

185

1222

1.52

6.84

1.4

1.3

4.88

4.94

umol/l

0.08

169

1123

(3000093) Morphology [Interpretation] in Blood Narrative

279

1995

1.40

6.83

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

286

2.10

6.81

1.3

1.4

6.19

245072.02

nmol/l

1.67

233

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

197

1324

1.49

6.72

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

109

636

1.72

6.71

1.4

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

275

2.11

6.68

1.1

1.3

—

(40768446) Kidney Pathology biopsy report

130

797

1.63

6.64

1.9

1.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

457

1.84

6.55

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

544

1.77

6.55

1.8

1.9

28.94

38.80

u/l

0.28

494

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

195

1316

1.49

6.53

1.4

—

(3019977) pH of Arterial blood

169

1108

1.53

6.50

2.5

7.41

7.43

0.76

399

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

339

1.98

6.50

5.7

5.9

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

197

1334

1.48

6.49

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

160

1038

1.54

6.46

1.6

1.9

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

125

765

1.64

6.45

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

172

1135

1.52

6.43

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

284

2062

1.38

6.39

2.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

420

3233

1.30

6.39

1.6

1.5

0.38

0.40

nmol/l

0.21

312

2523

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

469

1.82

6.35

1.3

1.1

99.35

83.39

1.57

129

(3004451) EKG impression Narrative

150

964

1.56

6.32

1.4

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

454

3536

1.29

6.32

1.1

1.76

2.04

u/ml

0.37

265

1834

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

272

1965

1.39

6.31

4.3

4.7

137.41

120.99

u/ml

0.11

621

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

159

1037

1.54

6.28

1.6

1.9

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

191

1295

1.48

6.27

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

138

872

1.59

6.26

2.4

—

(3024316) Viscosity of Plasma

2.94

6.25

1.4

1.7

1.35

1.66

mpas

2.29

(3038177) Helicobacter pylori Ab [Presence] in Serum

441

3431

1.29

6.20

1.3

1.2

—

(3006462) Nitrate [Presence] in Urine

157

1025

1.54

6.18

3.3

3.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

108

645

1.68

6.14

1.2

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

133

2.56

6.09

1.0

1.1

4.85

11.35

u/l

2.24

133

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

209

1452

1.44

6.07

1.4

1.6

21.80

24.34

u/ml

0.27

297

(3029075) Extractable nuclear Ab panel - Serum

104

618

1.69

6.04

1.0

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2347

21188

1.12

6.03

3.4

4.0

27.21

23.07

ug/l

0.20

1859

17071

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

186

1266

1.47

6.01

1.3

674.17

425.83

titre

0.24

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

493

1.77

5.98

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

493

1.77

5.98

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

493

1.77

5.98

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

493

1.77

5.98

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

102

605

1.69

5.97

3.1

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

102

605

1.69

5.97

3.1

2.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

892

7523

1.19

5.95

1.8

1.6

3.66

3.81

mg/l

0.20

684

5402

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

181

1229

1.48

5.93

1.3

76.67

57.90

titre

0.42

100

(3000475) Leukocytes [#/volume] in Synovial fluid

610

4965

1.23

5.87

1.7

1.6

9689.44

14053.54

e6/l

2.96

448

3590

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

107

2.71

5.83

1.6

1.2

1.16

1.09

0.03

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

468

1.78

5.82

1.2

82.79

72.06

0.75

125

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2317

20949

1.12

5.79

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

491

1.75

5.78

13.5

7.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

286

2.00

5.71

1.5

1.6

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

442

1.79

5.69

1.1

1.19

5.32

u/ml

0.93

368

(3003888) Timothy IgE Ab [Units/volume] in Serum

481

3832

1.26

5.63

1.1

3.78

5.69

u/ml

3.11

269

2011

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

139

904

1.54

5.61

2.2

22.79

233.07

ug/l

1.80

132

855

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

243

1760

1.38

5.61

1.4

1.3

1.47

1.42

nmol/l

0.29

219

1586

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

254

2.05

5.61

1.1

1.0

0.00

0.22

u/ml

1.19

160

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

105

640

1.64

5.57

1.8

1.9

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

128

2.50

5.51

2.1

1.4

14.22

13.06

0.09

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

218

1559

1.40

5.44

1.0

1.1

288.59

290.41

mg/l

0.14

196

1403

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

198

1395

1.42

5.38

1.5

1.4

12.55

12.71

u/l

0.13

190

1349

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

125

803

1.56

5.35

1.7

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

125

803

1.56

5.35

1.7

2.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

466

1.74

5.34

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

489

1.72

5.31

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

423

1.78

5.29

1.7

1.8

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

460

3676

1.26

5.27

1.1

1.11

1.17

u/ml

0.05

220

1627

(3037692) Legionella sp identified in Specimen by Organism specific culture

108

674

1.60

5.24

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

126

817

1.54

5.19

1.7

2.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

194

1375

1.41

5.13

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

319

1.88

5.12

1.5

1.6

—

(3042631) Mycobacterium sp identified in Specimen

348

2698

1.29

5.11

3.1

2.5

—

(3021788) Differential panel - Synovial fluid

468

3762

1.25

5.11

1.5

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

4.84

5.10

1.0

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

158

2.28

5.09

4.0

4.5

2.53

2.25

mg/l

0.43

133

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

489

1.70

5.05

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

103

642

1.61

5.04

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

179

1258

1.43

4.97

1.2

22.22

23.41

u/l

0.13

155

1068

(3014133) Dog dander IgE Ab [Units/volume] in Serum

375

2956

1.27

4.86

1.1

4.98

4.35

u/ml

0.15

208

1438

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

324

2507

1.30

4.86

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

491

3993

1.23

4.85

2.9

1.9

0.83

nmol/l

0.07

403

3349

(3006576) Bicarbonate [Moles/volume] in Blood

108

690

1.57

4.79

7.1

6.6

25.42

24.97

mmol/l

0.60

628

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

398

3168

1.26

4.76

1.1

81.90

3914.38

iu/ml

0.66

715

(3006270) Folate [Moles/volume] in Blood

230

1703

1.35

4.71

1.2

356.23

360.12

nmol/l

0.10

196

1418

(3040151) Glucose [Moles/volume] in Capillary blood

310

2399

1.30

4.66

8.1

9.4

7.11

7.44

mmol/l

0.90

247

1974

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

176

1250

1.41

4.64

1.0

37.08

43.36

ng/l

1.40

126

853

(3000330) Specific gravity of Urine by Test strip

1179

10379

1.14

4.62

4.1

3.5

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.33

4.59

1.0

—

(21494434) Karyotype in Bone marrow

231

1719

1.35

4.59

1.3

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

414

1.72

4.53

1.9

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

175

1248

1.41

4.52

1.0

787.42

724.31

ng/l

0.88

117

843

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

294

2271

1.30

4.50

1.2

66.40

62.98

u/l

0.10

264

2028

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

180

1292

1.40

4.48

1.2

96.18

89.40

u/l

0.28

159

1121

(3023430) Cat dander IgE Ab [Units/volume] in Serum

349

2758

1.27

4.47

1.1

6.74

5.12

u/ml

0.45

171

1165

(3038071) Oxygen [Partial pressure] in Mixed venous blood

431

1.70

4.46

14.5

7.5

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

105

2.48

4.44

1.2

1.3

—

13114.83

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

123

825

1.49

4.40

1.1

1.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

133

908

1.47

4.36

25.7

28.3

114.08

118.77

ug/l

0.33

105

771

(3008037) Lactate [Moles/volume] in Venous blood

527

4374

1.21

4.31

4.0

3.1

1.53

1.59

mmol/l

0.86

517

4277

(3025130) Human papilloma virus identified in Specimen

372

2977

1.25

4.30

1.7

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.95

4.28

2.1

2.2

1.50

2.49

mu/l

0.71

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

122

822

1.49

4.28

2.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1648

18216

0.90

4.25

1.7

—

(3020491) Glucose [Moles/volume] in Blood

207

1536

1.35

4.23

1.6

1.8

7.37

6.63

mmol/l

2.01

152

1104

(3020876) Protein [Mass/time] in 24 hour Urine

285

2216

1.29

4.18

2.2

2.6

1.08

1.27

g/24h

0.63

120

1091

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.85

4.18

1.2

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

210

1565

1.34

4.17

3.0

2.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

357

1.74

4.16

1.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

134

2.24

4.13

1.1

1.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

321

1.78

4.13

2.2

1.3

91.99

380.85

ng/l

0.56

205

(3044941) Cell count panel - Synovial fluid

393

3181

1.24

4.12

1.5

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

372

2993

1.25

4.12

1.1

3.82

3.25

u/ml

0.21

136

1398

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

466

3842

1.22

4.10

3.6

3.1

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

3.89

3.98

1.4

1.3

168.00

121.25

nmol/l

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

111

2.34

3.98

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

318

1.76

3.96

6.5

7.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

606

5138

1.18

3.95

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

439

1.64

3.94

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

329

2626

1.26

3.93

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

130

906

1.44

3.88

2.0

—

(3016031) Almond IgE Ab [Units/volume] in Serum

151

2.12

3.88

1.0

1.1

0.48

0.99

u/ml

0.58

(37021550) Renin [Units/volume] in Plasma --upright

420

1.64

3.81

1.3

60.86

92.33

mu/l

0.74

305

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

300

2379

1.26

3.80

1.1

0.47

0.41

u/ml

0.09

107

656

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.18

3.77

2.2

2.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

548

1.55

3.72

1.6

1.8

—

(3052592) Norovirus Ag [Presence] in Stool

408

1.64

3.71

1.3

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

502

1.58

3.68

1.5

0.41

0.39

ug/l

0.09

325

(43055442) Apixaban [Mass/volume] in Serum or Plasma

274

1.79

3.68

1.5

104.78

112.24

ug/l

0.21

230

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

169

1245

1.36

3.68

1.0

331.57

342.07

ng/l

0.08

121

870

(3038515) Glucose [Moles/volume] in Venous blood

492

4130

1.20

3.63

4.1

3.2

7.32

7.60

mmol/l

1.36

484

4048

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

142

2.11

3.63

1.5

1.2

—

(4034850) Laboratory test

764

6652

1.15

3.59

11.4

9.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

389

3199

1.22

3.57

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

137

981

1.40

3.55

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

137

981

1.40

3.55

1.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

143

1032

1.39

3.55

1.1

9.82

10.08

u/ml

0.02

173

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

285

1.76

3.53

1.0

83.31

78.56

ug/l

0.30

227

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

207

1582

1.31

3.53

1.6

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

294

1.74

3.47

1.1

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

125

888

1.41

3.41

7.9

4.0

151.20

1192.20

mg/l

1.38

640

(40765096) Chromosome analysis panel by Banding

568

1.52

3.41

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

387

3198

1.21

3.40

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

210

1620

1.30

3.36

2.0

1.9

3.83

3.82

mg/l

0.01

199

1534

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

7.00

3.36

1.0

21.29

22.20

umol/l

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

374

4510

0.83

3.32

4.0

3.4

24.35

27.05

mg/l

0.74

210

2880

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.71

3.31

5.1

6.5

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.41

3.29

10.1

9.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

318

2588

1.23

3.27

1.5

1.6

54.98

57.71

0.55

180

1616

(3045683) HLA typing for celiac disease panel - Blood or Tissue

168

1265

1.33

3.22

1.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

116

2.16

3.21

1.5

1.8

0.81

0.69

umol/l

0.41

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

302

1.69

3.19

1.6

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

123

2.11

3.18

1.0

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

302

2455

1.23

3.15

2.9

2.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

161

1211

1.33

3.12

1.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

662

1.45

3.11

1.1

22.82

9.13

u/ml

0.27

376

(3013336) Amino acids [Identifier] in Serum or Plasma

2.58

3.03

1.6

2.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

173

1321

1.31

3.03

1.1

1.16

2.81

u/ml

1.31

476

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

153

1.96

3.03

1.2

52.75

44.30

mg/l

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

119

2.10

3.03

1.0

1.1

0.11

1.76

u/ml

1.40

(3001686) Cold agglutinin [Titer] in Serum or Plasma

369

1.60

3.01

1.3

101.33

200.07

titre

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

340

2815

1.21

2.99

1.1

1.47

1.51

g/l

0.96

310

2553

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

425

1.55

2.98

1.2

149.55

28.42

mg/l

0.74

318

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

481

1.52

2.98

1.2

401.43

298.26

pmol/l

0.84

341

(3010370) Gastrin [Moles/volume] in Serum or Plasma

347

1.62

2.97

1.3

1.9

64.11

50.28

pmol/l

0.30

287

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

241

1926

1.25

2.96

1.3

7.81

8.34

mmol/l

1.62

226

1856

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.63

2.96

1.1

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

178

1370

1.30

2.95

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

108

771

1.40

2.93

1.2

—

(3049233) Organic acids panel - Urine

3.24

2.92

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

175

1346

1.30

2.92

1.7

1.6

5.59

6.88

u/l

0.78

147

1075

(3026480) Teichoate Ab [Titer] in Serum

163

1.90

2.88

1.1

1.0

—

2.33

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

493

5717

0.86

2.82

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

494

5727

0.86

2.82

1.4

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

116

2.07

2.81

1.0

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.33

2.80

1.4

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

177

1374

1.29

2.78

1.5

1.3

161.63

175.51

pmol/l

0.68

177

1374

(3042733) HLA Ab [Presence] in Serum

645

1.43

2.78

5.2

4.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

495

5731

0.86

2.78

1.4

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

8.33

2.75

1.8

2.7

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

492

5693

0.86

2.74

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

564

1.46

2.74

1.2

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.00

2.69

1.2

1.5

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

197

1.78

2.66

1.0

0.47

0.45

u/ml

0.01

109

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

438

1.51

2.64

5.7

5.5

69.11

69.13

0.00

342

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.18

2.56

3.9

4.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

119

885

1.35

2.56

1.2

—

(44813793) Dust mix specific IgE antibody measurement

197

1569

1.26

2.55

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

600

1.42

2.51

1.3

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

404

1.51

2.49

1.1

23.19

6.08

u/ml

0.52

290

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

209

1.72

2.49

2.2

2.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

986

10851

0.90

2.47

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

811

7284

1.12

2.47

2.9

3.4

514.02

1593.30

u/ml

1.65

679

6231

(3017569) Oxygen content in Arterial blood

120

900

1.33

2.46

1.7

2.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

159

1.82

2.42

1.0

1.1

—

(3012565) Volume of 24 hour Urine

137

1050

1.31

2.42

1.9

2.2

1874.55

1948.81

0.43

122

925

(3003129) Base excess in Capillary blood by calculation

505

1.45

2.41

2.0

1.7

0.46

0.55

mmol/l

0.08

474

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

138

1.88

2.40

1.4

26.16

16.52

pmol/l

0.39

115

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

219

1.69

2.40

1.0

0.01

2.50

u/ml

0.84

116

(3047352) Trisomy 18 risk [Likelihood] in Fetus

395

4591

0.86

2.39

1.4

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

115

1519

0.76

2.36

1.5

—

(3005033) Fetal Nuchal fold Thickness US

395

4582

0.86

2.34

1.4

—

(3002619) Bacteria identified in Specimen by Culture

435

1.47

2.33

1.2

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

141

1092

1.29

2.32

1.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.09

2.32

4.0

4.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

140

1084

1.29

2.31

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1253

11545

1.09

2.30

3.1

3.4

35.82

56.13

u/ml

2.99

1203

11135

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

119

1.93

2.29

1.0

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

215

1.68

2.27

1.0

0.02

0.64

u/ml

1.30

119

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

769

6932

1.11

2.22

1.4

1.5

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

290

2443

1.19

2.22

1.8

2.0

17.04

24.62

ug/l

4.54

282

2383

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.33

2.21

1.1

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

234

1933

1.21

2.21

1.5

1.4

160606.59

121458.00

e6/l

0.32

155

1336

(3045142) Bone marrow Pathology biopsy report

268

2243

1.20

2.21

1.3

—

(3044009) aPTT.lupus sensitive (LA screen)

187

1.71

2.19

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

583

1.39

2.19

2.1

1.8

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

541

6108

0.88

2.18

1.5

—

(3041184) Isoniazid [Presence] in Urine

3.33

2.17

2.8

2.4

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

3.33

2.17

1.1

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

123

946

1.30

2.16

4.7

3.7

—

(40759632) Porphyrins [Mass/mass] in Stool

3.68

2.15

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

166

1.75

2.14

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

126

974

1.30

2.13

1.3

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

126

974

1.30

2.13

1.3

1.7

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

235

1.62

2.12

1.0

1.1

1.43

4.05

u/ml

0.65

183

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

243

1.61

2.11

2.1

2.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

155

1232

1.26

2.11

1.5

1.4

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.26

2.07

3.3

1.4

72.67

136.97

ug/l

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

5.00

2.07

1.0

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

5.00

2.07

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

411

4698

0.87

2.03

1.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

130

1017

1.28

2.03

2.1

83.65

111.33

ug/min

0.22

225

(3001556) Androgen free Index in Serum or Plasma

208

1.64

2.00

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.00

1.99

39.2

9.0

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

2.28

1.97

1.0

0.04

0.11

u/ml

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

149

1.75

1.93

3.4

3.7

9.73

9.60

0.01

(3022475) Manganese [Moles/volume] in Blood

127

1.81

1.93

1.3

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

379

1.45

1.92

1.7

1.6

0.27

0.25

nmol/l

0.15

267

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.11

1.91

1.0

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.00

1.89

1.5

1.1

0.58

0.73

umol/24h

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

159

1286

1.24

1.89

1.1

2.94

4.93

u/ml

0.37

359

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

275

1.53

1.88

1.0

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

181

1.66

1.87

1.2

1.3

13.06

15.91

nmol/l

—

(4212803) Bone marrow aspirate examination

181

1.66

1.87

1.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

228

1.58

1.86

1.3

1.5

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.94

1.84

1.2

1.0

0.03

0.06

u/ml

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

182

1.65

1.84

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

309

1.49

1.84

1.6

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

649

1.33

1.79

1.1

8.57

11.68

u/ml

0.54

365

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

1.98

1.74

1.2

1.0

0.02

0.05

u/ml

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

219

1847

1.19

1.73

1.3

—

titre

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

209

1.58

1.73

2.6

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.67

1.72

1.1

1.0

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

103

1.85

1.71

8.7

11.7

211.37

247.49

e6/l

0.10

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

150

1222

1.23

1.71

20.3

18.1

1367.47

2195.29

nmol/l

0.54

142

1178

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

381

1.42

1.70

1.3

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.06

1.69

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

382

1.41

1.68

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

382

1.41

1.68

1.3

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.97

1.64

1.1

1.0

—

(3003577) Lead [Moles/volume] in Blood

142

1.69

1.64

1.3

1.4

0.13

0.20

umol/l

—

(3000034) Microalbumin [Mass/volume] in Urine

219

1860

1.18

1.62

3.0

58.92

48.33

mg/l

0.26

150

1336

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

310

1.45

1.62

1.2

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

156

1285

1.22

1.61

1.2

—

(3024471) HLA-A [Type]

661

1.30

1.60

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

189

1587

1.19

1.60

1.9

1.7

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.50

1.59

1.1

1.0

—

(40762814) Titanium [Mass/volume] in Blood

345

1.42

1.58

2.0

2.3

3.17

3.66

ug/l

0.49

126

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

157

1298

1.21

1.57

6.2

6.5

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

167

1.62

1.57

2.5

2.9

26.70

60.39

pmol/l

—

(3024932) HLA-DR beta [Type]

646

1.30

1.57

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

114

1.75

1.56

1.1

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

122

1.72

1.54

1.0

0.24

0.30

u/ml

0.13

110

(3002621) Streptococcal DNAse B [Units/volume] in Serum

224

1.52

1.53

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

614

1.30

1.52

1.1

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1141

12188

0.93

1.52

1.4

—

(3048879) Bone marrow aspiration report

571

1.31

1.51

1.9

1.8

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.59

1.51

1.0

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

125

1015

1.23

1.51

1.7

2.2

193.68

204.54

u/l

1.65

125

1006

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

225

1.51

1.50

1.0

0.27

0.13

u/ml

0.24

134

(3015350) Toxocara sp Ab [Presence] in Serum

2.86

1.50

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

123

1.71

1.50

1.6

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

154

1.62

1.49

4.9

6.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

139

1144

1.22

1.48

1.1

1.0

0.29

1.39

u/ml

1.39

317

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

679

1.28

1.47

1.8

2.1

9.09

9.33

mg/l

0.15

541

(1617658) Protocol used for examination of sentinel lymph nodes

135

1637

0.82

1.47

1.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

134

1101

1.22

1.45

1.2

1.1

27.15

24.42

u/l

0.12

119

990

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

195

1.54

1.45

1.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.88

1.44

1.4

1.6

—

(3047189) Immunofixation for 24 hour Urine

112

904

1.24

1.44

2.1

1.8

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.12

1.44

6.4

8.3

—

(3000285) Sodium [Moles/volume] in Blood

244

1.48

1.44

1.2

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

361

1.39

1.43

1.2

1.1

4.86

3.67

pmol/l

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

141

1168

1.21

1.42

14.2

12.7

791.03

826.95

nmol/l

0.41

134

1124

(3017509) Phencyclidine [Presence] in Urine

237

1.48

1.41

2.9

1.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

461

4165

1.11

1.41

2.8

3.4

265.40

837.26

u/ml

1.58

417

3783

(3027974) Hepatitis B virus e Ag [Presence] in Serum

111

1.71

1.38

1.3

1.6

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

549

5009

1.10

1.38

1.4

115.64

141.76

pmol/l

0.99

534

4881

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

434

0.67

1.38

1.2

—

(3004775) Volume in Urine collected for unspecified duration

135

1624

0.83

1.37

2.2

2.3

703.02

663.49

0.51

1112

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

554

1.30

1.37

1.5

1.7

97.32

148.25

au/ml

0.47

(40761539) Cells [Type] in Urine sediment by Light microscopy

537

1.30

1.37

1.1

1.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

314

1.40

1.36

1.4

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

348

1.38

1.35

1.3

1.2

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

175

1.54

1.33

1.4

1.3

1.28

1.63

ml/s/173m2

0.32

115

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

409

1.35

1.33

1.9

2.3

8.25

7.45

mmol/l

0.31

242

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

333

1.38

1.32

2.2

2.6

26.18

60.82

mg/l

—

(3024263) Appearance of Synovial fluid

130

1078

1.21

1.32

1.2

1.4

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

275

1.42

1.30

3.1

2.4

1.38

1.42

mmol/l

0.05

198

(3003843) Paprika IgE Ab [Units/volume] in Serum

2.08

1.27

1.0

0.21

0.06

u/ml

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

121

1001

1.21

1.27

1.3

1.5

5.20

3.82

0.33

228

(3011325) HIV 1+2 Ab [Presence] in Serum

1.72

1.26

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

107

1.68

1.25

1.8

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

219

1.46

1.25

1.1

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

352

0.65

1.24

4.7

5.9

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.40

1.24

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

132

1104

1.20

1.24

1.2

1.1

89.27

84.40

u/l

0.19

117

996

(3019174) dRVVT (LA screen)

187

1.50

1.23

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

108

1.67

1.22

1.0

1.1

—

(40761536) Microorganisms panel - Urine sediment

1909

18281

1.05

1.20

5.0

3.9

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.31

1.18

1.0

1.2

—

(3016750) Collection duration of Urine

1183

0.82

1.18

2.2

510.69

501.17

min

0.49

884

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

298

1.38

1.17

1.2

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

173

1.50

1.17

1.2

1.4

—

14.73

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.93

1.16

1.1

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

262

2324

1.13

1.16

1.4

1.5

1692.78

3180.76

e6/l

1.99

190

1675

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

102

1.67

1.16

1.3

1.29

1.71

mg/l

0.94

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

240

1.42

1.15

1.0

1.1

4.56

1.81

u/ml

0.47

187

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

2.50

1.15

1.0

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

2.50

1.15

1.0

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

438

1.30

1.14

2.1

2.5

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

284

1.37

1.11

2.4

2.7

52.73

75.97

pmol/l

0.88

245

(40761995) Spermatozoa Progressive [#/volume] in Semen

413

0.70

1.11

3.7

3.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

293

1.37

1.11

4.0

4.8

62.26

43.67

ug/min

0.57

228

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

412

0.70

1.10

7.3

6.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

459

1.29

1.09

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

713

1.22

1.05

2.7

97.19

162.84

au/ml

0.69

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.73

1.02

1.0

1.2

241.23

258.41

nmol/l

0.13

(3007542) Rye IgE Ab [Units/volume] in Serum

106

1.60

1.02

1.0

1.1

0.06

0.56

u/ml

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

130

1.54

1.02

2.0

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

786

7386

1.07

1.02

1.5

1.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

200

1763

1.14

1.01

1.3

298.21

513.82

u/l

3.26

188

1670

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

140

1203

1.16

1.01

1.4

5.59

5.67

mmol/l

0.26

135

1136

(3027540) Rickettsia typhi Ab [Titer] in Serum

2.00

1.00

1.0

1.1

—

(3035880) pH of Pleural fluid

124

1057

1.17

0.99

1.2

1.3

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

1.84

0.98

1.0

—

1.18

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.67

0.97

1.1

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.94

0.97

1.0

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

301

1.33

0.96

1.4

1.2

30.28

41.50

mg/l

1.16

257

(3017400) Magnesium [Moles/volume] in Urine

1.80

0.96

1.7

1.0

3.01

3.05

mmol/l

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

0.00

0.96

0.0

1.4

—

173.79

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

240

2672

0.90

0.93

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

109

1.56

0.93

1.3

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

597

1.22

0.92

1.3

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

517

4809

1.08

0.92

2.2

2.3

102.96

113.78

ug/min

0.21

304

2862

(3020356) Listeria sp identified in Specimen by Organism specific culture

134

1.49

0.91

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

184

1.41

0.91

1.2

78.46

106.76

ug/l

0.68

117

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

126

1.51

0.91

1.1

1.2

1.45

1.09

u/field

0.45

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

201

1.39

0.91

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

110

938

1.17

0.90

1.2

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

220

1973

1.12

0.88

1.2

1.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

775

1.19

0.87

3.5

3.3

7.42

8.12

mg/l

0.48

615

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

520

1.23

0.87

1.5

1.3

39.97

36.80

0.25

347

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

286

2601

1.10

0.87

2.1

32.98

32.54

1.11

286

2577

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

312

2854

1.09

0.85

2.5

2.7

377.31

666.87

u/ml

0.34

305

2817

(3028308) Erythrocytes [#/volume] in Pleural fluid

235

2121

1.11

0.84

1.4

1.5

44043.93

56486.45

e6/l

0.41

141

1252

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.63

0.84

1.5

1.3

475.58

528.71

nmol/l

0.12

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

696

1.19

0.84

1.4

63.55

62.93

0.06

580

(3007700) Barley IgE Ab [Units/volume] in Serum

1.56

0.84

1.0

1.1

0.06

0.71

u/ml

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.69

0.82

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

552

1.21

0.82

1.5

1.6

9.92

8.92

ug/l

0.86

552

(3025577) Chromium [Mass/volume] in Blood

138

1210

1.14

0.81

1.9

2.1

2.85

2.30

ug/l

0.42

114

1006

(3036670) Protein [Mass/volume] in Synovial fluid

626

1.20

0.81

1.3

1.2

42.65

39.51

g/l

1.32

331

(40757373) Influenza virus identified in Isolate

409

1.25

0.80

1.4

1.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.72

0.79

5.1

3.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

201

1809

1.11

0.78

1.3

1.4

6.38

6.30

mmol/l

0.19

192

1664

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.53

0.78

1.0

1.3

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.59

0.78

1.1

1.20

1.33

u/field

—

(3045788) Cell count panel - Pleural fluid

198

1783

1.11

0.76

1.5

—

(3000012) Reticulocyte production index

312

2873

1.09

0.76

2.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.70

0.75

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.08

0.74

2.0

2.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

215

1949

1.10

0.74

1.4

1.5

28.40

31.07

0.48

109

1203

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.64

0.73

1.0

1.2

—

mmol/l

—

(3009015) Lactate [Moles/volume] in Synovial fluid

219

1.32

0.73

1.4

1.2

5.81

6.25

mmol/l

0.20

104

(3003434) Protein [Mass/volume] in Pleural fluid

283

2603

1.09

0.72

1.4

1.5

32.04

33.02

g/l

0.68

253

2344

(40762887) Creatinine [Moles/volume] in Blood

1.80

0.72

1.6

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

159

1.38

0.72

2.9

3.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

460

4898

0.94

0.69

1.7

1.8

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

109

954

1.14

0.69

4.8

5.5

1180.88

4819.99

u/ml

0.44

166

(21494567) Legionella sp IgM Ab [Presence] in Serum

136

1.40

0.66

1.0

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

1.79

0.66

1.4

1.5

—

(40768793) Breast Pathology biopsy report

512

4837

1.06

0.65

1.3

—

(3026470) Cobalt [Mass/volume] in Blood

139

1243

1.12

0.64

1.9

2.0

4.13

3.60

ug/l

0.20

127

1137

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

324

3479

0.93

0.64

3.9

3.6

30.10

38.35

u/ml

0.84

315

3365

(3032641) Amino acids panel - Urine

1.72

0.64

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

305

1.25

0.63

1.1

1.2

—

(3022670) pH of Venous cord blood

1.60

0.61

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

629

1.16

0.60

1.0

—

(3044316) Mercury [Moles/volume] in Urine

0.00

0.59

0.0

2.0

—

7.94

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.51

0.58

1.3

1.0

—

(3015183) Erythrocyte sedimentation rate

116

1035

1.12

0.58

1.2

—

(3007463) Buprenorphine [Presence] in Urine

1.46

0.57

8.5

5.6

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.46

0.57

1.6

1.4

—

(4281824) Cell count and differential, peritoneal fluid

218

2363

0.92

0.57

1.2

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.71

0.57

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

132

1.36

0.56

1.0

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.67

0.56

4.7

4.6

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

292

1.23

0.56

1.3

1.4

8.47

12.70

0.49

151

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

440

0.82

0.55

2.3

1.8

1.67

2.96

ug/l

1.12

266

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

150

1.33

0.55

3.5

4.9

—

(36303858) Crystals [Presence] in Urine

1.62

0.55

1.0

1.2

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.62

0.55

1.2

1.6

2.23

2.08

mmol/24h

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

891

0.88

0.55

1.1

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

275

1.24

0.55

1.6

1.3

—

(40768800) Prostate Pathology biopsy report

335

3565

0.94

0.54

1.1

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

177

1.30

0.54

1.7

1.6

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

160

1.31

0.53

2.5

2.4

—

(3001729) Color of Synovial fluid

170

0.71

0.53

1.2

1.7

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

133

1205

1.10

0.52

1.2

1.3

1.55

1.56

g/l

0.04

133

1205

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.52

0.52

1.1

1.0

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

1.43

0.52

1.7

2.5

0.08

0.14

ug/l

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.50

0.51

1.0

1.1

4.00

2.72

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.50

0.51

2.0

2.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

248

0.77

0.51

1.1

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

207

1.26

0.49

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

167

0.72

0.49

1.2

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

109

0.64

0.48

1.0

—

(40768795) Lymph node Pathology biopsy report

194

2090

0.93

0.47

1.2

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

1.43

0.46

2.3

1.3

0.10

6.29

mg/l

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.43

0.45

1.0

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

524

1.15

0.45

2.7

139.05

114.01

ng/l

0.44

275

(3002331) Protein [Mass/volume] in Peritoneal fluid

439

0.84

0.45

1.5

1.4

22.87

29.07

g/l

0.83

341

(3050129) First trimester maternal screen panel - Serum or Plasma

703

7285

0.96

0.43

1.5

1.4

—

(3018001) Oat IgE Ab [Units/volume] in Serum

148

1.28

0.43

1.1

1.0

0.35

0.19

u/ml

0.22

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

122

1.31

0.42

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.40

0.42

1.0

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

879

1.10

0.41

2.0

1.9

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

249

1.21

0.41

1.4

1.3

232.32

324.09

u/l

0.16

182

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

150

0.73

0.41

1.0

5.14

3.21

kpa

0.58

129

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

177

1.24

0.40

10.0

7.9

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.39

0.38

1.2

1.1

1656.00

1837.50

titre

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

216

1.20

0.36

3.6

3.2

1.67

1.12

mg/l

0.67

149

(3013862) HLA-DP [Type]

1.27

0.36

1.0

—

(3012441) Differential panel - Pleural fluid

212

2002

1.06

0.35

1.4

1.5

—

(3010937) Rubella virus Ab [Presence] in Serum

126

1.27

0.35

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

199

1.21

0.34

2.3

1.7

44.17

46.88

umol/l

0.16

199

(3005082) Progesterone [Moles/volume] in Serum or Plasma

105

1136

0.92

0.33

1.4

33.00

31.46

nmol/l

0.17

1035

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1011

0.92

0.33

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

719

0.90

0.33

2.0

13380.34

1836.22

e6/l

0.53

495

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

632

0.90

0.30

1.9

5856.06

11945.40

e6/l

0.72

342

(40758358) Immune stain study

0.71

0.30

1.0

—

(42870560) Thyrotropin [Units/volume] in Cord blood

164

0.79

0.30

1.0

8.43

8.37

mu/l

0.02

136

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

715

0.91

0.30

2.1

2.4

148.27

149.67

nmol/l

0.04

616

(3027570) Oxalate [Moles/time] in 24 hour Urine

129

1.24

0.30

1.9

1.4

392.69

312.59

umol/24h

0.77

129

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

438

1.12

0.30

1.2

1.1

37.94

61.49

u/ml

3.32

426

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

126

1179

1.07

0.29

1.6

1.8

1.58

2.79

u/field

2.55

823

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

161

1521

1.06

0.29

1.2

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

176

1.19

0.28

1.8

1.9

65.36

58.19

0.38

108

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.27

0.27

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

305

2935

1.04

0.27

1.5

1.3

3.07

3.90

ug/l

1.06

267

2605

(3039443) Prostate specific Ag panel - Serum or Plasma

292

3036

0.96

0.27

1.5

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

262

1.15

0.26

1.3

1.2

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.26

0.26

2.3

3.4

—

0.00

—

(3044007) Cell count panel - Peritoneal fluid

562

0.91

0.26

2.2

1.9

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

288

0.87

0.25

1.4

1.3

0.83

1.39

mmol/l

0.60

189

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

254

1.14

0.25

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

245

1.14

0.24

1.1

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

189

1.16

0.24

1.5

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

180

1.17

0.23

1.1

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

519

5324

0.97

0.23

1.5

—

(40768441) Liver Pathology biopsy report

160

1529

1.05

0.21

1.4

1.3

—

(3030703) Everolimus [Mass/volume] in Blood

0.00

0.21

0.0

17.1

—

5.08

—

(3003157) Bacteria [#/volume] in Mother's milk

1.16

0.21

4.0

7.1

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.20

0.0

1.7

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.20

0.0

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.20

0.0

1.1

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.20

0.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

259

1.12

0.20

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

541

0.92

0.19

1.2

1.3

354.61

337.30

ug/l

0.03

287

(3001019) Free T4 and TSH panel - Serum or Plasma

1085

10695

1.02

0.18

1.6

1.7

—

(3006598) pH of Arterial cord blood

153

0.85

0.18

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

243

1.11

0.17

7.8

7.5

—

(3009677) Dengue virus Ab [Presence] in Serum

1.22

0.17

1.1

1.2

—

(46236302) HLA-C [Type] by High resolution typing

1.16

0.16

1.0

—

(40763590) HLA-DQ beta [Type]

1.16

0.16

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

370

0.92

0.16

1.4

1.2

2.04

1.62

mmol/l

0.71

224

(3000919) Neutrophils/100 leukocytes in Pleural fluid

536

1.06

0.15

1.4

22.03

21.35

0.07

484

(46235168) Fasting glucose [Moles/volume] in Blood

236

1.10

0.14

1.2

2.3

7.89

7.67

mmol/l

0.04

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

103

1.17

0.13

1.3

1.2

—

(3014891) Appearance of Pleural fluid

247

1.09

0.13

1.4

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

117

0.85

0.13

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

113

1172

0.96

0.13

2.0

1.7

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

142

1.13

0.12

1.0

1.1

3.72

8.64

u/ml

—

(40758292) HTLV I+II Ab panel - Serum

326

1.07

0.12

1.3

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

175

1704

1.03

0.12

1.7

2.1

2.65

2.11

u/field

0.46

710

(3041806) Other cells [#/volume] in Blood by Manual count

858

1.04

0.11

1.6

1.4

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

134

1.12

0.10

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

218

0.92

0.10

1.2

1.1

18.86

20.18

u/l

0.18

145

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

259

0.93

0.10

2.3

2.5

0.83

0.61

u/field

0.44

259

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.06

0.09

7.4

5.4

0.19

0.22

mmol/l

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

625

1.04

0.09

1.4

56.73

55.32

0.12

538

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.13

0.09

1.2

0.06

0.07

g/l

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

370

0.95

0.09

1.7

—

(40763791) Oxygen content in Venous blood by calculation

1.03

0.08

6.8

4.7

11.57

11.87

ml/dl

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.03

0.08

1.0

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

461

1.04

0.07

1.3

1.4

25.08

22.45

0.24

395

(40768806) Pleura Pathology biopsy report

200

2032

0.98

0.07

1.4

1.5

—

(3023383) Lactate [Moles/volume] in Pleural fluid

601

1.03

0.06

1.3

3.04

3.48

mmol/l

0.73

552

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

948

1.02

0.06

3.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

602

1.03

0.06

1.4

2.99

2.78

0.09

508

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

217

1.06

0.06

3.8

3.3

—

(3033799) Differential panel - Peritoneal fluid

618

0.97

0.06

1.8

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

131

0.92

0.05

1.1

1.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

141

1387

1.02

0.05

1.3

11.02

13.87

u/l

2.06

125

1282

(3021162) Amylase [Enzymatic activity/volume] in Specimen

336

1.04

0.05

3.3

2.7

1051.00

1925.13

u/l

0.53

309

(3026692) Albumin [Mass/volume] in Peritoneal fluid

505

0.97

0.05

1.3

1.4

13.03

13.68

g/l

0.20

378

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

171

0.94

0.05

2.8

2.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

528

5315

0.99

0.04

5.2

4.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

605

0.98

0.04

2.3

2.9

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

308

1.04

0.04

2.5

3.1

—

(3020650) Glucose [Presence] in Urine

544

0.97

0.04

1.8

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

406

4088

0.99

0.04

1.5

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

134

1.04

0.00

1.0

—

(3008607) Semen analysis panel

109

1.01

0.00

1.1

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

109

1.01

0.00

2.1

3.5

—

(3009871) Measles virus Ab [Titer] in Serum

705

1.01

0.00

1.9

1.7

—

(3026726) Creatinine [Moles/volume] in Specimen

164

0.98

0.00

2.4

158.38

359.25

umol/l

1.13

156

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

296

2959

1.00

0.00

1.3

7.24

7.16

mmol/l

0.19

270

2608

(3022689) Creatine [Moles/volume] in Urine

586

1.01

0.00

1.3

1.5

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.03

0.00

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

167

1.02

0.00

1.2

1.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

140

1.00

-0.00

2.1

1.8

11.00

17.75

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(37019676) Renin [Units/volume] in Plasma --supine

0.86

-0.00

2.0

1.1

47.08

76.36

mu/l

—

(3013931) Oligosaccharides [Presence] in Urine

0.00

-0.00

0.0

1.1

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

1.01

-0.00

1.0

—

(3045191) Normetanephrine [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.7

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3013762) Body weight Measured

0.88

-0.00

1.3

1.1

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

-0.00

0.0

2.5

—

4.00

—

(3016072) Theophylline [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(40760410) HLA-B [Type] by High resolution

1.01

-0.00

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_VISUDISTURB and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_VISUDISTURB	1.19 [1.08, 1.31]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.113

During the follow-up period (1.1.1998 — 31.12.2019), 8393 out of 74214 females with H7_VISUDISTURB died.

Males

Parameter	HR [95% CI]	p-value
H7_VISUDISTURB	1.357 [1.23, 1.5]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 9442 out of 60739 males with H7_VISUDISTURB died.

Mortality risk

Mortality risk for people of age

years, who have H7_VISUDISTURB.

N-year risk	Females	Males
1	0.077%	0.284%
5	0.616%	1.577%
10	1.601%	3.993%
15	3.134%	7.248%
20	5.535%	12.138%

Relationships between endpoints

↥

Index endpoint: H7_VISUDISTURB – Visual disturbances

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Visual disturbances

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints